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ABSTRACT 
Gastric cancer is the fifth most common occurred cancer worldwide. The predominant 
higher incidence of gastric cancer among males and the diminishing difference after age of 60 
years suggests a potential protective effect of female hormones. In Chapter One, we found late 
age at natural menopause was associated with reduced risk of gastric cancer (≥55 vs. ≤ 45years 
old: HR=0.50, 95% CI: 0.25-0.99). Greater years of menstrual cycling were associated with a 
decreased risk of gastric adenocarcinoma (4th versus 1st quartile: HR=0.67, 95%CI: 0.46-0.96). 
Both ever use of oral contraceptives (OCs) and hormone replacement therapy (HRT) were also 
associated with reduced risk of gastric adenocarcinoma; the HRs (95% CIs) were 0.40 (0.17-0.90) 
for use of HRT >3 years and 0.67 (0.47-0.94) for ever use of OCs, compared with never use. In 
Chapter Two, a prospective analysis of composite lifestyle factors and gastric cancer risk further 
elucidated that composite scores representing healthy lifestyles were significantly associated with 
reduced risk of gastric adenocarcinoma in a dose-dependent manner. HRs (95% CIs) for total, 
cardia, and non-cardia gastric adenocarcinoma for the highest (score 5) versus lowest composite 
score (score 0/1/2) were 0.42 (0.31-0.57), 0.22 (0.10-0.47), and 0.55 (0.39-0.78), respectively (all 
Ptrend<0.001). These findings are very encouraging for a comprehensive strategy for promoting 
healthy living that could be effective for primary prevention of gastric cancer even in populations 
with a relatively high background risk of gastric cancer and high prevalence of H. pylori. No 
prospective evidence was available to elucidate the association between extreme telomere length 
 v 
and gastric cancer risk. In Chapter Three, we conducted a prospective analysis found that both 
extreme short (1st vs. 2nd quintile: HR=1.63, 95% CI: 1.08-2.47) and long (5th vs. 2nd quintile: 
HR=1.55, 95% CI: 0.97-2.47) telomere length is associated with increased risk of gastric 
adenocarcinoma. The public health significance of these findings is the identification of novel 
modifiable risk factors among certain population subgroups with high risk of gastric 
adenocarcinoma and paving way for future preventative strategies. 
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1. INTRODUCTION 
1.1 GASTRIC CANCER WORDWIDE INCIDENCE AND TIME TREND 
Gastric cancer poses a heavy public health burden globally. It is the fifth most commonly 
diagnosed malignancy worldwide with 951,594 incident cases (age-adjusted incidence rate: 12.1 
per 100,000) and the third leading cause of cancer deaths with 723,073 deaths (age-adjusted 
mortality rate: 8.9 per 100,000) based on the 2012 estimates by International Agency for Research 
on Cancer (IARC)1. More than 70% of incident cases developed in developing countries. Higher 
incidence rates were observed in South Korea, Japan, China, and Latin American and Eastern 
European countries. About 50% of incident cases occurred in Eastern Asia2. For example,  gastric 
cancer was the seventh most common cancer among male Chinese (age-adjusted incidence rate: 
10.7 per 100,000) and the ninth most common cancer among female Chinese in Singapore (6.8 per 
100,000)3.  
The past four decades have witnessed the declining of gastric cancer incidence especially 
among high risk regions such as Japan, China and Singapore with an average 50% reduction in 
rate2. Although the prognosis of patients with gastric cancer has greatly improved; the 5-year age-
adjusted relative survival rate of gastric cancer though improved by as far as 50% from 14.3% in 
1975 to 28.8% in 2007 in the United States, but still remained lower compared with other cancer 
sites such as colorectal (64.9%) and breast (89.4%) cancer. In high risk regions such as Eastern 
Asia, the survival rate ranged from less than 20% for less developed countries to around 31-58% 
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for China, Japan and South Korea. For developed countries in high risk regions such as Japan, 
gastric cancer patients had a better prognosis with 54% 5-year survival rate due to early detection4.  
1.2 GASTRIC CANCER RISK FACTORS 
1.2.1 Helicobacter pylori 
Helicobacter pylori (H. pylori) infection was the strongest environmental risk factor for 
non-cardia gastric cancer development accounting for 75% of prevalent cases worldwide5. The 
prevalence of H. pylori infection varies substantially worldwide with the highest rate of 80% in 
high-risk area for gastric cancer such as Eastern Asia and the lowest rate of 30% in Western 
Europe6. H. pylori infection has also been classified as group I carcinogen by IARC since 19947. 
A meta-analysis of 12 nested case-control studies in the prospective cohort has shown that H. 
pylori infection was associated with more than doubled risk of gastric cancer (OR=2.36, 95%CI: 
1.89-2.81)8. When the results were stratified by cardia versus non-cardia anatomical type, the 
association only appeared among non-cardia cases (OR=2.97, 95%CI: 2.34-2.77) and became even 
stronger for samples collected more than 10 years before cancer diagnosis (OR=5.93, 95%CI: 
3.41-10.30)8. There is possible biological plausibility explaining why H. pylori infection was not 
associated with cardia gastric cancer risk. H. pylori infection causing atrophy gastritis leads to 
reduction in gastric acidity and further alleviate the extent of gastroesophageal reflux disease 
(GERD)8. It has been well established that GERD was associated with risk of developing 
esophageal and cardia gastric adenocarcinoma9. The CagA H. pylori was the most investigated 
marker for virulence and possesses cag pathogenicity island5. CagA positive strain types of H. 
pylori was associated with an elevated risk of gastric cancer than CagA negative strain types based 
on a meta-analysis of 16 prospective cohort and case-control studies (OR=2.01, 95% CI: 1.21-
3.32)8. The underlying biological mechanisms for H. pylori increasing risk of non-cardia gastric 
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cancer include overexpression of growth factors such as epidermal growth factor receptor (EGFR), 
methylation of cellular adhesion genes such as E-cadherin (CDH1), inactivation of tumor 
suppressor genes such as p53 and runt-related transcriptional factor 3 (RUNX3) and initiation of 
chronic inflammatory responses increasing pro-inflammatory cytokines levels such as IL-8 and 
TNFα6. 
1.3.2 Environmental risk factors 
Tobacco smoking is the leading environmental risk factor for gastric cancer development 
after H. pylori infection. Since 2004 it has been classified as group I carcinogen by IARC10. A 
meta-analysis of 27 cohort studies showed a 62% increased gastric cancer risk for current versus 
never smokers among males (RR=1.62, 95% CI: 1.50-1.75) and 20% among females (RR=1.20, 
95% CI: 1.01-1.43)11. There are more than 70 known carcinogens in cigarette smoke including 
tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons (PAH)12. Tobacco smoke 
also contains high level of nicotine which could promote carcinogenesis. In vitro studies showed 
that nicotine could activate nicotinic acetylcholine receptors (nAChRs) and induce cellular 
proliferation in gastric cancer cell lines by upregulating cyclooxygenase 2 (COX-2)13. It could also 
increase phosphorylating extracellular signal-regulated kinase-1/2 (ERK1/2) to further activate the 
downstream signaling pathways involving COX-2 and ERK14. Previous study also found that 
CagA positive H. pylori infection acts synergistically with cigarette smoking to increase risk of 
non-cardia gastric cancer. The risk of gastric cancer increased by almost 16-fold for current 
smokers and infected with CagA positive H. pylori compared with non-current smokers who were 
not infected15.  
Heavy alcohol consumption is associated with elevated gastric cancer risk. In human body, 
ethanol is metabolized to acetaldehyde, a group I carcinogen classified by IARC, and further 
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oxidized into nontoxic acetate16. In vivo studies have shown an increased incidence of stomach 
adenocarcinoma in rats administered with the highest acetaldehyde concentration compared with 
the lowest level16. A review of 15 cohort and 44 case-control studies found that heavy drinkers (≥ 
4 drinks/day) had a 20% higher gastric cancer risk than nondrinkers (RR=1.20, 95% CI: 1.01-
1.44)17. A possible explanation is that alcohol could damage gastric mucosa layer and enhance H. 
pylori adherence to gastric mucosa, as higher alcohol consumption increased H. pylori infection18.  
Mounting evidence showed that high intake of red meat or processed meat could increase 
gastric cancer risk. Based on a review of 12 cohort and 30 case-control studies, both red meat and 
processed meat increased gastric cancer risk by 45%19. Heme iron intake from red meat could 
endogenously convert into carcinogens such as N-nitroso compounds (NOCs) as study showed a 
highly significant correlation between heme iron from red meat and endogenous NOCs 
formation20. In the EPIC cohort, highest heme iron intake level from red meat was found to be 
associated with a 67% increase in gastric adenocarcinoma risk (HR=1.67, 95% CI: 1.20-2.34) 
compared with the lowest level21. For fruits and vegetables consumption, a meta-analysis of 24 
cohort studies found a significant 10% reduction in risk of gastric cancer associated with highest 
levels of fruit (RR: 0.90, 95% CI: 0.83-0.98) and vegetables using a validated assessment method 
(RR: 0.90, 95% CI: 0.79-1.01)22. Antioxidants such as vitamin C in fruit and vegetables can inhibit 
the endogenous NOC formation. Also carotenoids, vitamin C and E in fruits and vegetables cast 
effect on DNA methylation modulation, induce detoxification of phase II enzymes and promote 
cellular apoptosis23, 24.  
Sodium intake and gastric cancer association have been extensively studied in different 
populations. Two in vivo studies in rats showed that administration of high concentration of sodium 
chloride (1.3-4.5 M) caused immediate damage to gastric mucosa, increased cellular proliferation, 
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and altered the viscosity of gastric mucosa25, 26. A review of 11 cohort studies found a significant 
association between highest level of salt intake and gastric cancer risk, especially in Japan (RR 
ranged from 2.2-5.4) where salt intake was much higher than elsewhere27.  
Obesity could increase the risk of gastro-esophageal reflux diseases (GERD) which is 
associated with high risk of esophageal and gastric cardia adenocarcinoma28. Overweight and 
obesity (BMI≥25) increased gastric cancer risk by 20% based on a review of 10 cohort studies (6 
from non-Asian populations and 4 from Asian populations) (OR=1.22, 95% CI: 1.06-1.41) and 
especially for gastric cardia cancer (OR=1.55, 95% CI: 1.31-1.84)29. High BMI and increased 
gastric cancer risk was biologically plausible. Pro-inflammatory cytokines produced from excess 
body fat could lead to chronic inflammation. In vitro study showed that overexpression of 
interlukin-1β could lead to inflammation in gastric cells and eventual carcinoma development30. 
Also excess body fat could upregulate insulin-like growth factor-1 (IGF-1) which stimulates 
cellular proliferation and inhibit apoptosis31. 
1.3 PROPOSED GASTRIC CARCINOGENESIS MODEL 
Approximate 90-95% of gastric cancer cases are adenocarcinomas and originate from 
glandular epithelium of the gastric mucosa, while another 5-10% cases are non-Hodgkin’s 
lymphomas and stromal tumors32. By anatomical sites, gastric cancer could be classified as cardia 
gastric cancer and non-cardia gastric cancer. An estimated 27.3% of incident gastric cancer cases 
in 2012 were cardia gastric adenocarcinoma33. Based on Lauren’s classification, there are two main 
histological types of gastric cancer: intestinal and diffuse type. Intestinal type gastric cancer is 
more related with dietary and environmental risk factors and eventually develop into gland-like 
structures through multistep progression34. On the other hand, diffuse type gastric cancer was less 
common accounting for 15% of all cases in the US35. Diffuse type gastric cancer lacks glandular 
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structures and premalignant lesions, more poorly differentiated and has worse prognosis than 
intestinal type gastric cancer34. The Correa’s model was the most widely used gastric cancer 
pathology model to define the precancerous lesions development for intestinal type gastric cancer. 
It postulated that the intestinal type of gastric cancer was the end result of progressive changes in 
the gastric mucosa, starting with chronic gastritis, followed by multifocal atrophic gastritis (MAG) 
and intestinal metaplasia (Figure 1). H. pylori infection plays an essential role in this model and 
CagA positive H. pylori strain type was oncogenic and was associated with a higher risk of 
developing gastric pre-neoplastic lesions36. 
1.4 IDENTIFICATION OF GASTRIC CANCER RISK FACTORS 
Worldwide gastric cancer incidence rates are twice as high in men than in women5, 33. 
While lower exposure to risk factors such as cigarettes smoking and alcohol consumption among 
women may partly explain the lower incidence rate of gastric cancer, higher lifetime exposure to 
estrogens may also contribute to their overall lower risk of gastric cancer. This notion is also 
supported by the fact that the male to female ratio in gastric cancer incidence rates peaks at 2.5 
around age 60 and then declines to as low as 1.5 after age 60, suggesting a diminishing protective 
effect for women during their post-menopausal year37, 38. Therefore, we hypothesize that 1) longer 
cumulative exposure to endogenous circulating female hormones, and 2) postmenopausal hormone 
use (such as hormone replacement therapy and oral contraceptives) are associated with decreased 
risk of gastric cancer (Chapter 1). 
Several modifiable lifestyle factors have been identified as risk factors for gastric cancer. 
These risk factors are cigarette smoking11, heavy alcohol consumption17, obesity29, high sodium 
intake39, low physical activity40, low vegetable and fruit intake41 and high red meat intake19. People 
choose a lifestyle that would be determined by most, if not all, of these factors. Therefore, these 
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lifestyle factors are correlated with each other. People with more healthy lifestyle factors may have 
lower risk of gastric cancer than those with fewer factors if each of these factors provides an 
additional effect. Thus we hypothesized that a higher composite score of protective lifestyle factors 
would be associated with a lower risk of developing gastric adenocarcinoma (Chapter 2).  
Telomeres are tandem nucleotide repeats of TTAGGG and locate at the end of eukaryotic 
chromosomes42. Telomeres play an important role in maintaining chromosome stability by 
preventing degradation, atypical combination, and chromosome ends fusion43. Progressive 
shortening of telomeres occur as a consequence of somatic cell divisions and is associated with 
increasing age44. Several other factors have also been identified to be associated with decreasing 
telomeres length including cigarette smoking45 and oxidative stress46. When telomere shortens  to 
a critical point,  the cell undergoes cellular irreversible growth arrest, replicative senescence and 
apoptosis47. On the other hand, extreme long telomere length could indicate upregulation of 
telomerase, a reverse transcriptase enzyme helping maintain telomere length. Long telomere length 
thus increased chance of abnormality with occurrence of more cell divisions48. Though 
retrospective evidence indicated that extreme short and long telomere length were associated with 
increased risk of gastric cancer, no prospective evidence is currently available. Thus we 
hypothesized a U-shaped association between telomere length and risk of gastric cancer (Chapter 
3).  
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2. CHAPTER ONE: FEMALES HORMONES AND GASTRIC CANCER 
2.1 PREVIOUS STUDIES 
Previous evidence from epidemiologic studies investigating reproductive factors and 
exogenous hormone use associations with gastric cancer risk support the notion that high level of 
estrogens may offer some protection against gastric cancer for women. A recent meat-analysis 
showed that longer menstrual cycling (i.e. window between menopause and menarche) of more 
than 39 years was associated with 26% reduced risk of gastric cancer compared with less than 27 
years49. Women who reported ever use of hormone replacement therapy (HRT) had a statistically 
significant 23% reduced risk of gastric cancer49. However, these results were heavily weighted by 
findings from populations with low risk of gastric cancer and may not be generalized to high-risk 
populations. For example, HRT use was not associated with risk of gastric cancer in prospective 
cohort studies conducted in Japan50 or China51. The lower prevalence of ever HRT use in Asians 
(e.g., 2% in Chinese women51 compared with the 55% in the US52) may have contributed to a null 
association in Asian cohort studies. Thus we conducted statistical analyses among a prospective 
cohort study of Chinese in Singapore to evaluate whether associations were present between 
reproductive factors and/or exogenous hormone use and gastric cancer risk in a relatively high-
risk population with a relatively high prevalence of exogenous hormone use, compared with other 
Asian populations. 
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2.2 METHODS AND MATERIAL 
2.2.1 Study design and population 
The Singapore Chinese Health Study (SCHS) was a prospective cohort study conducted 
among a total of 63,257 middle-aged and older (45-74 years) Singapore Chinese men and 
women between 1993 and 199853. The participants were citizens or permanent residents of 
Singapore and spoke one of the two major dialect groups (Hokkien or Cantonese). At 
recruitment, baseline in-person interviews were conducted using a structured questionnaire for 
each participant to obtain demographics, body weight and height, tobacco smoking and alcohol 
consumption, physical activity, diet, medical history and family history of cancer. A validated, 
semi-quantitative food frequency questionnaire (FFQ) including 165-food items was used to 
assess the subject’s usual in the past 12 months. For women only, a specific section of the 
questionnaire asked for histories of reproductive factors (i.e., age at first menstrual period, 
menopausal status, age at last menstrual period, age at first birth, and number of births), use of 
oral contraceptive (OC) pills (age at starting to use, total number of years used), HRT (age at 
starting to use, total number of years used), and history of hysterectomy (with or without ovaries 
removed). In the first (FU1) and second (FU2) follow-up telephone interviews that took place in 
1999-2004 and 2006-2010, respectively, menopausal status and HRT use were updated. Ninety-
one percent of female cohort participants who were alive completed FU1 survey that updated 
information on menopausal status, use of exogenous hormones and other lifestyle factors. The 
FU2 survey was completed on 82% of women who completed FU1 and were alive that provided 
another update on menopausal status and use of exogenous hormones. The current study 
included 34,022 female participants of the Singapore Chinese Health Study (SCHS). This study 
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was approved by the Institutional Review Boards at the National University of Singapore and the 
University of Pittsburgh (Pittsburgh, PA). 
2.2.2 Case ascertainment 
All incident gastric cancer cases among the SCHS participants were identified through 
the linkage analysis with The Singapore Cancer Registry under the National Registry of Diseases 
Offices (NRDO) of Singapore. Starting from 1968, this national cancer registry provides 
information on cancer patterns and trends in Singapore and has been shown to be comprehensive 
in recording of incident cancer cases54. Gastric cancer was defined using the International 
Classification of Disease Oncology, 3rd edition (ICD-O-3) as C16.0-C16.9. As of December 31, 
2013, 315 gastric cancer cases had been identified among female participants of SCHS. Among 
those identified cases, 269 adenocarcinoma (8140/3-8560/3) cases were included in our final 
analysis. Excluded cases included 18 sarcomas (8800/3-8936/3), 14 lymphomas (9590/3-9699/3) 
and 14 unspecified histology types. 
2.2.3 H. pylori and chronic gastritis infection status 
To further study the potential associations with years of menstrual cycling, HRT and OC 
use for gastric cancer risk while adjusting for H. pylori infection and chronic atrophic gastritis 
status, a nested matched case-control study was conducted among 187 female participants. 
Details of this sub-study have been previously reported55. A total of 48 female gastric cancer 
cases and 139 controls matched on age at study enrollment (within 3 years), father’s dialect and 
date of sample collection (within 6 months) were included in this analysis. Three H. pylori 
antigens including CagA (116 kD), VacA (89 kD), and UreA (30 kD) were  quantified using a 
validated assay to determine subject’s H. pylori past and current infection status56. Plasma 
pepsinogen I (PG I) and II (PG II) were measured to define atrophic gastritis status using cutoff 
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points of PG I<70 ng/mL and PG I:II ratio <3, as recommended by the manufacturer (LZ Test 
“Eiken” Pepsinogen I and II, Tokyo, Japan).  
2.2.4 Statistical analysis 
Cox proportional hazards regression models were performed to calculate hazard ratios 
(HRs) and corresponding 95% confidence intervals (CIs) to examine the associations between 
exogenous hormone use (HRT and OC) and reproductive factors, and gastric cancer risks among 
all 34,022 female participants. Person-years of follow-up were computed from the enrollment 
date to the date of gastric cancer diagnosis, death, migration out of Singapore, or December 31, 
2013, whichever occurred first. The proportional hazards assumption was examined by testing 
the significance of Pearson’s correlation coefficient between Schoenfeld residuals of exogenous 
hormone use and ranked survival time. We found no violation of proportional hazards 
assumption. 
HRT use was defined as ever taking estrogens with or without progesterone for the 
purpose of alleviating symptoms of menopause or other reasons, and was determined based on 
the information reported at baseline and two follow-up surveys. Figure 1 depicts the algorithm 
used to estimate the total duration of HRT use. The person-years of follow-up for the HRT use 
model was calculated from the date of the most recent questionnaire (i.e., baseline, FU1 or FU2) 
to the censor date, as described above.   
To estimate the cumulative duration of exposure to endogenous sex steroid hormones, we 
calculated the number of years of menstruation in the following manner:    
 [(Age at menopause or baseline interview for premenopausal women)-(Age at menarche)]-
[(9/12)*(Number of Births)]-(years of OC use) 
Age at menopause and type of menopause were ascertained at the baseline survey. Age at 
menarche, age at natural menopause, and quartile categories of menstrual cycling years were 
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used in multivariable models to investigate their associations with gastric cancer risk. In 
addition, the following reproductive factors were evaluated in relation to gastric cancer risk: 
parity (nulliparous, parous), age at first birth (≤20 years, 21-25 years, 26-30 years and ≥31 years) 
among parous women, number of births (0, 1-2, 3-4, ≥5), and combined oophorectomy and 
hysterectomy status (no oophorectomy or hysterectomy, hysterectomy with no ovary removed, 
oophorectomy with or without hysterectomy).  
Covariates selected as potential confounders for the present analysis were those that had 
been previously reported to be associated with gastric cancer risk in our study population55 or 
those that were associated with any HRT and/or OC use and gastric cancer risk (both P 
values<0.10) in addition to factors related to the selection and enrollment of study subjects. The 
final set of covariates included in the multivariable regression models were age at interview (in 
years), baseline interview year (1993-1995, 1996-1998), father’s dialect (Cantonese, Hokkien), 
body mass index (in kg/m2), educational level (no formal education/primary education and 
≥secondary education), smoking status (never/former and current), daily coffee intake (non-daily 
drinkers and daily drinkers), and sodium intake (in mg/day). Adjustment for additional variables 
including intake of fruit or vegetables, or history of gastric/duodenal ulcer did not materially 
change the association between reproductive factors or exogenous hormone use and gastric 
cancer risk. Thus these results are not shown in the present report. BMI was evaluated as a 
potential effect modifier on the relationship between selected exposures and risk of gastric 
cancer by conducting stratified analyses by BMI, and by evaluating whether an interaction term 
(e.g., hormone use x BMI) was statistically significant in the multivariable model. 
To examine the association between reproductive factors or exogenous hormone use and 
gastric cancer risk with the adjustment for H. Pylori infection status, a nested matched case-
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control study design was used based on the available measurement of serological status of H. 
pylori on the selected cases and controls only. To maximize the number of subjects included in 
the analysis, unconditional logistic regression was used to calculate odds ratios (ORs) and their 
corresponding 95% CIs for gastric cancer for all participants and for participants with positive H. 
pylori infection only, which was defined by the serologic status of CagA. Other serological 
biomarkers such as VagA and UreA did not add much information on the determination of H. 
Pylori infection status, thus these two serological biomarkers were not included. Included in the 
models were covariates for the matching factors (age at baseline, dialect group, and date of 
biospecimen collection), as well as interview year, cigarette smoking, body mass index, coffee 
intake, and sodium intake. Further adjustment for atrophic gastritis status did not materially alter 
the ORs for gastric cancer among participants with positive CagA status, therefore these results 
are not shown. 
All statistical analyses were performed in SAS 9.3 software package (SAS Institute, Inc.). 
All P values reported were two-sided. P values <0.05 were considered to be statistically 
significant. 
2.3 RESULTS 
At baseline, study participants had a mean age of 56.3 years [standard deviation 
(SD)=8.0]. Women who reported ever HRT and/or OC use were younger, had higher intake of 
sodium, higher level of education, were less likely to smoke cigarettes, and less likely to have 
menopause by natural means (Table 1.1). Risk of gastric cancer was inversely associated with 
level of education (≥secondary level versus <secondary level: HR=0.79, 95% CI: 0.54-1.17) and 
positively associated with current versus never/former smoking status (HR=1.41, 95% CI: 0.94-
2.11) and body mass index (≥28 versus <20 kg/m2: HR=1.35, 95% CI: 0.81-2.26). The 
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association with daily alcohol consumption was very imprecise (daily versus nondrinker: 
HR=1.28, 95% CI: 0.47, 3.43).  
The associations between reproductive factors and gastric cancer risk are shown in Table 
1.2. Age at menarche and age at first birth were not associated with risk of gastric cancer. Parity 
was inversely associated with gastric cancer risk, and a non-linear trend was observed with 
number of children, compared with nulliparous women. History of hysterectomy with or without 
oophorectomy was not associated risk of gastric cancer whereas history of oophorectomy 
regardless of hysterectomy was associated with a reduced, but statistically non-significant 
association for gastric cancer. Compared with natural menopause, other non-natural type was 
associated with a 52% reduction of gastric cancer risk. Further adjustment for ever HRT and/or 
OC use did not change the association (HR=0.51; 95% CI: 0.28-0.92 for non-natural versus 
natural menopause). Among women who reported having menopause by natural means, 
increasing age at menopause was associated with a decreased risk of gastric cancer (P for trend = 
0.04); women who had natural menopause at 55 years or older had a 50% lower risk of gastric 
cancer compared to those with menopause before 45 years of age. Overall, the highest quartile 
range of menstrual cycling years was associated with a 33% reduced risk of gastric cancer among 
premenopausal and natural postmenopausal women compared with the lowest quartile range 
though there was no evidence for a trend.   
The associations between use of HRT and OC and risk of gastric cancer are shown in 
Table 1.3. HRT use was associated with a 28% reduced risk of gastric cancer compared with 
never use. The reduced risk was more pronounced for women who used HRT for more than 3 
years. Similarly, ever use of OC was also associated with a statistically significantly reduced risk 
of gastric cancer (HR = 0.67, 95% CI = 0.47-0.94). The mutual adjustment for HRT and OC use 
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did not materially change the observed association between use of HRT or OC and gastric cancer 
risk (data not shown). Further adjustment for menopausal type (i.e., non-natural versus natural), 
the associations with HRT use remained (HRT ever versus never use, HR=0.73; 95% CI: 0.43-
1.24; and HRT use >3 years versus never use, HR=0.40; 95% CI: 0.18-0.92).  
The association for gastric cancer risk in relation to exogenous hormone use and total 
number of years of menstrual cycling over lifetime was further examined among a subset of 
study subjects with available measurement of H. pylori infection (CagA) status (Table 1.5). 
Similar to the results based on the entire cohort, a reduced risk of gastric cancer was observed for 
ever versus never use of exogenous hormones (HRT and/or OC) in all subjects as well as in 
those with positive CagA of H. pylori of this subset, although the inverse association did not 
reach the statistical significance level due to small sample size. For years of menstrual cycling, a 
statistically significant inverse association was observed for the third versus first quartile. The 
inverse association was still present, but no longer statistically significant among those positive 
for H. pylori.   
2.4 DISCUSSION 
In prospective analyses using data from a population-based cohort of Chinese in 
Singapore, we reported statistically significant inverse associations for gastric cancer risk with 
greater years of menstrual cycling, non-natural cause of menopause, older age at natural 
menopause, and hormone use. The strongest inverse association was for more than 3 years of 
HRT use, with a statistically significant 60% risk reduction, compared with never use. Results 
from prospective cohort studies among populations with low background risk of gastric cancer 
incidence support an inverse association between HRT use and gastric cancer risk52, 57. Our 
findings, among a population with a high background risk of gastric cancer, are consistent with 
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previous studies and lend further support for the notion that longer exposure to high circulating 
estrogens confers a reduction in gastric cancer risk.    
In a meta-analysis conducted with results from five prospective cohort studies and two 
case-control studies, ever HRT use was associated with a statistically significant lower gastric 
cancer risk (summary RR=0.77, 95%CI: 0.64-0.92)49. Results from two Asian cohorts 51, 58 were 
included, but their risk estimates contributed only 8.6% weight to the summary RR, compared 
with 74% weight from the US and European cohort results. In the only Asian prospective cohort 
study that evaluated HRT use and gastric cancer incidence, no association was observed with 
ever use51. However, the prevalence of HRT use among participants of that cohort was only 
2%51. In the present study, 12.6% reported ever HRT use. With a higher prevalence of HRT use, 
the present study provided greater statistical power for us to evaluate and detect a modest effect 
of HRT use on gastric cancer risk. 
Our finding for a statistically significant inverse association between OC use and gastric 
cancer risk has not been observed in other studies. Previous studies reported a positive57, 
inverse59, and null51, 52 association between OC use and risk of gastric cancer in various 
populations. While a possible chance finding, there is biologic plausibility for a protective effect 
of OCs on gastric cancer development. OCs inhibit ovulation in part by decreasing production 
and secretion of follicle-stimulating hormone (FSH) and luteinizing hormone60, 61. In rats, 
administration of FSH resulted in increased markers of oxidative stress62. Reactive oxygen 
species can result in genomic DNA damage that initiates and/or promotes carcinogenesis63, 64. 
Accumulation of oxidative DNA damage has been elevated in tissues of the stomach of patients 
with intestinal metaplasia, a precursor of gastric cancer65. There remains, however, a lack of 
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direct evidence between OC use and decreased gastric tissue-specific oxidative stress in humans. 
Future studies are warranted to confirm our findings. 
We evaluated the relationship between reproductive factors and gastric cancer risk, 
because factors, such as later age at menopause and years of menstrual cycling not only are 
associated with increased levels of circulating estrogens and/or their metabolites66, but also 
represent longer period of cumulative exposure to sex hormones67. Thus, these factors may be 
associated with lower gastric cancer risk. We reported statistically significant inverse 
associations for gastric cancer risk with greater years of menstrual cycling (>34.4 versus ≤28.4). 
Our results for menstrual cycling years are consistent with results from the European Prospective 
Investigation into Cancer and Nutrition (EPIC) cohort, where a statistically significant inverse 
association between years of menstrual cycling and gastric cancer risk (>37 versus <27 years: 
HR=0.55, 95% CI: 0.31-0.98) was reported57.  
We also reported statistically significant inverse associations for gastric cancer risk with 
non-natural cause of menopause and with older age at natural menopause (≥55 versus <45 
years). The mean age at menopause (i.e., 49 years) in our cohort was similar to European (i.e., 50 
years) and U.S. (i.e., 49 years) populations 68, 69. Compared with women who had a natural 
menopause, those who had non-natural menopause had a younger age at menopause and were 
more likely to be users of HRT and/or OC, which could have masked an inverse relationship in 
the previous studies that combined women with different menopausal types and reported no clear 
relationship 52, 57. In our study, when women with non-natural cause of menopausal were 
included in the analysis, we did not observe a statistically significant association between age at 
menopause and gastric cancer risk (data not shown). Although the inverse association with non-
natural menopause was only slightly attenuated after adjusting for age at menopause and 
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hormone use (HR=0.45; 95% CI: 0.25, 0.83), the finding should be interpreted cautiously. It was 
not possible to completely remove the potential confounding effects of age at menopause or HRT 
use, or other, unmeasured factors on the menopause type-gastric cancer association. In addition, 
our finding was inconsistent with the results of no association 50, 52 and a positive association51 
that have been reported for surgical menopause.  
Our findings of no association for gastric cancer risk was observed with age at menarche 
or age at first birth were consistent with findings from previous epidemiologic studies49. The 
mean age at menarche (i.e., 14.4 years) in our cohort was slightly older compared to European 
(i.e., 13.0 years) and U.S. (i.e., 12.7 years) populations 68, 70 Compared with nulliparous women, 
having three to four children was inversely associated with gastric cancer, but no association was 
seen for having 5 or more children. Most previous prospective studies have not observed 
associations with parity or a trend with increasing number of births57, 71. Having more full-term 
births is not directly related to circulating estrogens72, so if having children protects against 
gastric cancer, the mechanism is not likely to be hormonally driven.  
An important role of estrogens in gastric carcinogenesis has been documented in animal 
studies that show lower markers of cell proliferation and lower gastric cancer incidence 
following carcinogen administration in male versus female rats73, 74. 17β-Estradiol can suppress 
the pathologic changes, such as atrophy, hyperplasia, intestinal metaplasia and dysplasia in 
gastric epithelium of mice infected with H. pylori75. A hypothesized biologic mechanism for 
such a protection includes increased expression of the trefoil factor family (TFFs) proteins76, 
which are expressed in the normal gastric mucosa77, 78. In addition, their expression is increased 
around the site of mucosal injury and is shown to contribute to mucosal repair by promoting 
epithelial restitution79, 80. TFF1 expression in estrogen-receptor positive breast cancers was 
19 
positively correlated with plasma estradiol levels in postmenopausal patients81. In contrast, 
TFF3, also known as intestinal trefoil factor (ITF) is not expressed in normal gastric mucosa and 
instead is expressed by goblet cells in areas of intestinal metaplasia. ITF expression is reported in 
55% of all gastric cancers, and is correlated with aggressive phenotype 82. Serum levels of TFF3 
are associated with later stage at diagnosis of gastric cancer (P=0.002), and are higher among 
patients compared with unaffected controls (P<0.0001) 83. The relationship between estrogen and 
TFFs in the gastrointestinal tract are unclear, but may shed light on the protective mechanisms 
behind the lower risk of gastric cancer observed in women, compared with men. 
The strengths of our study include its large sample size of over 34,000 participants and 
relative long follow-up, with a mean of 16 years. The prevalence of ever HRT use was low 
(around 3.7%) at baseline and more women started to use HRT at later age after menopause. By 
incorporating the follow-up information, 12.6% of the study participants reported ever HRT use 
at either baseline, FU1 or FU2. Our ability to update status during follow up likely provided 
more accurate measures of exposure than if we had relied only on information collected at 
baseline. Our study had more statistical power to detect a possible inverse association between 
exogenous hormone use and gastric cancer risk compared with previous studies conducted in 
populations with high gastric cancer incidence. Pre-diagnostic biospecimens were available 
among a subset of our samples allowing for further investigating the exogenous hormone use-
gastric association among participants with atrophic gastritis and positive H. pylori infection 
status.  
Our study also has several limitations. We did not have information on specific types and 
dosage levels of HRT and OC used by the study participants. There could be potential variations 
of exogenous estrogen exposure level between participants even if they have similar duration of 
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use. This could lead to non-differential misclassifications and possibly bias the results towards 
null. Second, we applied an algorithm to estimate total duration of HRT use. It is possible that 
we could have under or overestimated duration of HRT use, but any misclassified duration 
calculations are likely to be random, which would typically attenuate the HRT-gastric cancer risk 
association.     
Greater years of menstrual cycling, older age at natural menopause, non-natural 
menopause, and hormone use are associated with a statistically significant decrease in gastric 
cancer risk in a prospective cohort of Chinese women in Singapore. Our results support the 
notion that an underlying estrogenic mechanism is responsible, in part, for the lower incidence of 
gastric cancer in women compared with men. Future prospective studies are needed to verify our 
findings in other populations with a high background risk of gastric cancer.  
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3. CHAPTER TWO: COMPOSITE LIFESTYLE FACTORS AND GASTRIC CANCER 
3.1 PREVIOUS STUDIES 
There have been only two prospective cohort studies that examined the association between 
combined lifestyle factors and risk of gastric cancer; both of them were conducted in the European 
countries where incidence rate of gastric cancer is lower (9.4 per 100,000) than the world average 
(12.1 per 100,000)1. In the European Prospective Investigation into Cancer and Nutrition (EPIC) 
cohort, a composite index of three healthy lifestyle factors was associated with a statistically 
significant reduced risk of gastric adenocarcinoma84. The other study in France with a composite 
index of five lifestyle habits was also associated with a reduced risk of cancer of digestive system 
including the esophagus, stomach, biliary tract, small bowel, and pancreas38. To our knowledge, 
there has been no study investigating the composite score of multiple lifestyle factors in relation 
to risk of gastric cancer in Asian populations, which are at moderate to high risk for gastric cancer. 
The findings from low-risk European populations may not be applicable to moderate- to high-risk 
Asian populations. Therefore we conducted an analysis for the associations between composite 
score of lifestyle factors consisting of cigarette smoking, alcohol consumption, BMI, dietary 
pattern and sodium intake, and risk of gastric adenocarcinoma in a prospective cohort of Chinese 
men and women in Singapore who were at medium risk of gastric cancer (11.9 per 100,000)3.  
3.2 METHODS AND MATERIAL 
3.2.1 Study design and population 
The Singapore Chinese Health Study (SCHS) was a prospective cohort study conducted 
among a total of 63,257 middle-aged and older (45-74 years) Singapore Chinese men and women 
between 1993 and 199853. The participants were citizens or permanent residents of Singapore and 
22 
spoke one of the two major dialect groups (Hokkien or Cantonese). We excluded 1,936 subjects 
who had a history of cancer at baseline. Thus the present analysis included 61,321 participants. 
The SCHS was approved by the Institutional Review Boards at the National University of 
Singapore and the University of Pittsburgh (Pittsburgh, PA). 
3.2.2 Case ascertainment 
Gastric cancer cases among the SCHS participants were identified through the linkage 
analysis with The Singapore Cancer Registry under the National Registry of Diseases Offices 
(NRDO) of Singapore. This nationwide registry has collected information on individual cancer 
patients and national cancer trends and patterns since 1968 3 and has been shown to be 
comprehensive in recording incident cancer cases16. Gastric cancer was defined using the 
International Classification of Disease Oncology, 3rd edition (ICD-O-3) as C16.0-C16.9. By 
December 31, 2014, a total of 801 incident cases of gastric cancer were identified among all 
participants of SCHS. Among them, 32 were sarcomas, 29 lymphomas and 49 unspecified 
histology types cases were excluded. Thus the present study included 691 cases of gastric 
adenocarcinoma, of which 118 were cardia, 491 were non-cardia and 82 site unspecified cases. 
3.2.3 Assessment of lifestyle factors and composite lifestyle score 
For all study participants, baseline interviews between 1993 and 1998 were conducted in 
person using a structured questionnaire to elicit subjects’ information on age, height, weight, level 
of education, tobacco use, physical activity, medical history and usual adult diet including alcohol 
consumption. The structured semi-quantitative food frequency questionnaire (FFQ) listed 165 
dietary items that represented all major Chinese food and beverage items in Singapore. For each 
dietary item, each subject was asked to choose a consumption frequency among 8 pre-defined 
categories from “never or hardly ever” to “two or more time a day” along with a portion size of 
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the item assisted with a food photo album. This FFQ was validated subsequently in a sub-cohort 
of our study population53.  
For cigarette smoking, each ever smoker was asked the following questions: “What is the 
average number of cigarettes that you smoked per day?” and “What is the total number of years 
that you smoked cigarettes on a regular basis?” Total number of pack-years of smoking was 
calculated as the number of packs (20 cigarettes per pack) smoked per day multiplied by the 
number of years of smoking.   
For daily ethanol consumption, participants were asked “How often did you drink each 
type of beverage including beer, rice wine, grape wine and hard liquor during the past year?” and 
“What was the usual serving size of this type of beverage?” Daily consumption of each type of 
alcoholic beverage was calculated by frequency multiplied by the serving size. Thus total daily 
ethanol consumption was the sum of ethanol over all types of alcoholic beverages consumed.  The 
average ethanol content is 13.5 g in one drink (375 ml) of beer, 10.85 g in one drink (30 ml) of 
rice wine or hard liquor, and 11.68 g in one glass (118 ml) of grape wine.  
Daily sodium intake was derived from validated FFQ and the Singapore Food Composition 
Table that also provides sodium content for each of 165 dietary items (mg per 100 g). The final 
value of sodium intake was adjusted for total energy intake (mg per 1,000 kcal).  
Dietary pattern was determined using the principal component analysis (PCA) as described 
previously85. Briefly, we identified two dietary patterns among SCHS participants: vegetable-fruit-
soy (VFS) and meat-dim-sum (MDS). VFS was characterized by high intake of fruits, vegetables 
and soy foods whereas MDS by high intake of pork, chicken, dim-sum foods and noodle dishes, 
respectively. For each subject, the average of the two VFS (ascending order) and MDS (descending 
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order) ranking scores (range 1 to 100) was calculated for the present analysis, a high score was 
indicative of a high intake of VFS and a low intake of MDS (Table 2.6). 
Two sets of algorithm were applied for construction of composite protective lifestyle score 
based on dichotomized cutoff and Z-score of each factor. In the first algorithm, each lifestyle factor 
was dichotomized and final cutoff value was chosen to reflect the strongest effect size for its 
univariate association with gastric adenocarcinoma risk. Pack-years of smoking was categorized 
at median (i.e., 21.9) among ever smokers (low risk/protective lifestyle score 1= <21.9, 0= ≥21.9). 
Daily ethanol consumption was categorized at 8.1 g (the third tertile) among ever drinkers (1= 
<8.1, 0= ≥8.1). Dietary pattern score was categorized at 62 (the fourth quartile) of the entire cohort 
(1= ≥62, 0= <62). Daily sodium intake was categorized at 782 mg per 1000 kcal (the third tertile) 
(1= <782, 0= ≥782). BMI was categorized at ≥27.5 kg/m2 for obesity recommended by the World 
Health Organization  for Asian populations 86 (1= <27.5, 0= ≥27.5 kg/m2). The percentages of the 
study population in high or low score of these five individual lifestyle factors are presented in 
Table 2.7. The final composite protective lifestyle score was the sum of 5 individual lifestyle 
factors:  represeted the lowest and 5 the highest protective lifestyle score.  
The second algorithm was to generate sex-specific Z-score for each lifestyle factor to avoid 
over-fitting the model based on dichotomized values of individual lifestyle factors. In the study 
population, approximately 70% of participants were never smokers and 81% never consumed 
alcoholic beverages.  Thus the Z-scores for pack-years of smoking and daily ethanol consumption 
were derived from ever smokers and ever alcoholic drinkers, respectively. We assigned half of the 
lowest Z-score for pack-years of smoking and daily ethanol to never smokers and never drinkers, 
respectively. The composite healthy lifestyle Z-score was the sum of Z-score for all five individual 
factors for each study subject as follows: 
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Composite Z-score=Z diet – (Z smoking + Z drinking + Z BMI + Z sodium).  
A higher composite Z-score stands for higher score presenting healthier dietary pattern, 
lower pack-years of smoking, lower ethanol consumption, lower BMI and lower sodium 
consumption. The distribution of single lifestyle factor by quartile of composite Z-score was 
shown in Table 2.8. 
3.2.4 H. pylori infection status testing 
To further examine the association of composite protective lifestyle score in combination 
with H. pylori infection status in relation to gastric adenocarcinoma risk, a nested case-control 
study was conducted involving 522 subjects (133 gastric adenocarcinoma cases and 389 
individually matched controls) whose serological H. pylori infection status was determined by the 
presence or absence of CagA 116 kDa in serum. 
3.2.5 Statistical analysis 
Person-years at risk for each of 61,321 eligible subjects were computed from the date of 
enrollment to the date of gastric cancer diagnosis, death, migration out of Singapore, or December 
31, 2014, whichever occurred first. Cox proportional hazard regression method was employed for 
calculation of hazard ratios (HRs) and their corresponding 95% confidence intervals (CIs) of 
gastric adenocarcinoma associated with individual lifestyle factors and both the composite 
protective lifestyle scores derived from dichotomized cutoff and Z-score of these lifestyle factors 
together. Test for liner trends was conducted by treating the composite lifestyle score as a 
continuous variable in the Cox model. The proportional hazards assumption was examined by 
testing the significance of Pearson’s correlation coefficient between Schoenfeld residuals of the 
composite lifestyle score and ranked survival time87. We found no violation of proportional 
hazards assumption. 
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To adjust for potential confounding, age, sex, dialect group, year of recruitment, and level 
of education were included in all regression models. Further adjustment for other covariates such 
as intake of individual vegetables and fruit, family history of cancer and history of gastric/duodenal 
ulcer did not meaningfully alter the association between the composite lifestyle score and gastric 
adenocarcinoma risk. Thus the results presented were not adjusted for these variables.  
Population attributable risk (PAR) estimate was computed for the proportion of gastric 
adenocarcinoma cases that would be avoided on a population level attributable to higher composite 
lifestyle category. Based on the HRs from Cox proportional hazard regression model and their 
variance-covariance matrix and the prevalence of each unique combinations of the covariates in 
the model, an algorithm developed by Spiegelman and colleagues  was applied to calculate partial 
PAR along with its 95% CIs while age, sex, dialect group, year of recruitment, and level of 
education remain unchanged 88.  
 To examine the potential modifying effect of subclinical symptoms of gastric cancer on 
the association between composite protective lifestyle score and gastric adenocarcinoma risk, we 
conducted sensitivity analyses on subset of dataset divided by the length of follow-up, e.g.  ≤5 
years and >5 years. To investigate the association between composite lifestyle score and gastric 
adenocarcinoma risk with adjustment of H. pylori infection status, conditional logistic regression 
model was performed in the nested case-control study for all subjects and for subjects with positive 
H. pylori infection status defined by positive CagA test results. Stratified analyses were performed 
by anatomical sites such as cardia and non-cardia of the stomach.  
All statistical analysis was performed in SAS 9.4 software package (SAS Institute, Inc.). 
All P values reported are two-sided. P values <0.05 were considered to be statistically significant.  
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3.3 RESULTS 
With increasing composite lifestyle score, there was an increase in proportion of women 
and a decrease in BMI. A higher composite lifestyle score was also characterized by fewer current 
smokers, lower pack-years of smoking, and lower daily intake of ethanol, sodium and red meat 
(Table 2.1). The distributions of individual lifestyle factors across different composite score of 
protective lifestyle factors are shown in Table 2.9. These individual lifestyle factors were not or 
moderately correlated each other (all correlation coefficients < 0.23). 
After more than one million cumulative person-years of follow-up (mean 16.9 years per 
subject), as of December 31, 2014, a total of 801 incident cases of gastric cancer were identified 
among all participants of SCHS. Among them, 32 were sarcomas, 29 lymphomas and 49 
malignancies with unspecified histology; all of them were excluded from the present analysis. 
Thus the present study included 691 cases of gastric adenocarcinoma; among them, 118 were 
cardia, 491 were non-cardia and 82 were unspecified subsite of the stomach. The mean duration 
between baseline interview and the diagnosis of all gastric adenocarcinoma cases was 6.9 years 
(standard deviation = 3.9).  
Individual scores of all five protective lifestyle factors separately were significantly 
associated with a 18-34% reduction in HR of gastric adenocarcinoma (Table 2.2). The association 
was stronger for BMI with risk of cardia than non-cardia cancer (Table2.2). HR and 95% CIs for 
individual risk factor (before dichotomized) and gastric adenocarcinoma risk are presented in 
Table 2.10. The cut-off value of each lifestyle factors was chosen based on their risk association 
with gastric adenocarcinoma for the creation of composite score. High composite score of 
protective lifestyle factors was significantly associated with reduced hazard ratio of gastric 
adenocarcinoma in a dose-dependent manner (Table 2.2). Compared with the lowest composite 
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scores using dichotomous cutoff (0-2), HRs (95% CIs) of gastric adenocarcinoma for composite 
scores of 3, 4, and 5 protective lifestyle factors were 0.68 (0.52-0.88), 0.51 (0.40-0.66), and 0.42 
(0.31-0.57), respectively (P trend < 0.001). This association was stronger for cardia than non-
cardia cancer (Table 2.2). Based on the distribution of the composite score, we estimated that 48% 
of total gastric adenocarcinoma, including 72% in cardia and 43% in non-cardia, could be 
attributable to these five risk factors combined.  
We also examined the association between Z-score of single lifestyle factor and gastric 
adenocarcinoma risk (Table 2.11). High Z-score for individual lifestyle factors were associated 
with increased risk of gastric cancer except for dietary pattern, which was inversely associated the 
risk though of statistical significance.  
When these Z-score were summed up after reversing the Z-scores for risk lifestyle factors 
(see Methods section), high composite Z-score was associated with statistically significant, 
reduced risk of gastric adenocarcinoma (Table 2.2). Although weaker than the composite score of 
the dichotomized lifestyle protective factors, the inverse association was strong and in dose-
dependent manner, and present for both cardia and non-cardia cancers.  (Table 2.2). This inverse 
association between composite score of protective lifestyle factors, either derived from 
dichotomized categories or Z-scores, and gastric adenocarcinoma risk was present in both men 
and women (Table 2.3) and for both short (≤5 years) and long (>5 years) duration of follow-up of 
the entire cohort (Table 2.4).  
To take into account the impact of H. pylori infection on the observed risk association, we 
conducted similar analysis in a nested case-control study within the SCHS whose serological status 
of H. pylori infection was determined by the presence or absence of CagA in serum. There was a 
statistically significant inverse association between composite score of dichotomized lifestyle 
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factors and gastric adenocarcinoma risk among all subjects of the case-control study after 
adjustment for H. pylori infection status as well as among subjects with positive CagA status only. 
A similar inverse association was observed for both cardia and non-cardia cancer. For composite 
Z-score, the association slightly attenuated after adjustment for H. pylori infection status and 
among subjects with positive CagA status, especially for non-cardia cases, given the small sample 
size (Table 2.5).  
3.4 DISCUSSION 
The present study demonstrates that a high composite score of five healthier lifestyle 
factors including smoking, alcohol consumption, BMI, a diet high in vegetables/fruit and low in 
red meat, and low intake of dietary sodium is significantly associated with reduced risk of 
developing gastric adenocarcinoma in an Asian population with high prevalence of H. pylroi. The 
highest composite score was associated with a statistically significant 58% decreased risk of gastric 
adenocarcinoma compared with the lowest composite score. These lifestyle factors together can 
account for up to half of the disease burden in this study population, of which approximately 85% 
had a history of infection with H. pylori.  
To our knowledge, the present study is the first prospective study to examine the 
association between combined lifestyle factors and gastric adenocarcinoma risk in an Asian 
population with high H. pylori prevalence. There are only two previous reports, both in low-risk 
European populations, on the composite lifestyle factors and gastric cancer risk. In the EPIC study 
with 11.4 years of follow-up, highest score of 3 lifestyle factors (cigarette smoking, alcohol 
consumption, and adherence to a Mediterranean diet) was associated with a significant 50% 
decrease in risk of gastric adenocarcinoma 84.  The E3N (Etude Epidémiologique auprès de femmes 
de la Mutuelle Générale de l'Education Nationale) study in French women  with 15 years of 
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follow-up showed similar results; the highest score of protective lifestyle factors, including 
abstinence from smoking, low to moderate alcohol drinking (less than 2 drinks/day), normal range 
of BMI (18.5-25 kg/m2), high recreational physical activity and high vegetable and fruit intake, 
was associated with a statistically significant 40% decrease in  risk of cancer in the digestive tract  
gastric cancer38. The findings of the present study are consistent with those in low-risk populations.   
Z-score based lifestyle composite score is significantly associated with risk of gastric 
adenocarcinoma in a dose-response manner although its association was slightly weaker than the 
categorical based composite score. As a complementary approach to the categorical based 
composite score, Z-score method corroborates the inverse association between adaption of healthy 
lifestyle factors and reduced risk of gastric adenocarcinoma.  Z-score based composite score was 
based on the standardized values for each factor with equal weight, which addressed the issue of 
data overfitting. However, this complete data-driven approach may not optimize the stratification 
of study subjects at risk, thus could lead to a weaker association between the summed Z-score and 
gastric cancer risk.   
The strengths of our study include the prospective study design, unique study population 
(Southeast Asians), a relatively large sample size (63,000 participants), long-term follow-up (17 
years) and serological status of H. pylori infection. A summary lifestyle factor score can classify 
individuals into more homogenous groups by their risk profile that minimizes potential 
misclassification and residual confounding effect. The main limitation is that all the information 
on lifestyle factors was self-reported at baseline with inherent non-differential misclassification, 
that could bias the risk estimates towards null. Therefore, the observed risk estimates may be lower 
than the true effect of these lifestyle factors on the risk of gastric adenocarcinoma. It should also 
be noted that our estimate of daily sodium intake may have missed some dietary sources, which 
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may cause some biased results. Given a prospective study design, both cancer cases and non-
cancer individuals answered to the same dietary questionnaire. Thus, if there is any 
misclassification, it would be non-differential and lead to an underestimated risk association.  
Future studies using urinary excretion of sodium over 24 hours are warranted to confirm our 
findings.  
 In conclusion, we observed a strong, statistically significant association between high 
composite score of protective lifestyle factors and reduced risk of gastric adenocarcinoma. 
Altogether these factors can account for up to almost half of disease burden in this Asian 
population with a very high prevalence of H. pylori.  These findings are very encouraging for a 
comprehensive strategy for promoting healthy living that could be effective for primary prevention 
of gastric cancer even in populations with a relatively high background risk of gastric cancer and 
high prevalence of H. pylori.   
32 
4. CHAPTER THREE: TELOMERE LENGTH AND GASTRIC CANCER 
4.1 PREVIOUS STUDIES 
Based on a meta-analysis of 16 case-control and 11 prospective studies, shortened 
telomeres were associated with cancer risk including bladder, esophageal, gastric, ovarian, head 
and neck, and renal cancer cases89. A more recent case-control studies on telomere length and 
gastric cancer risk among Han Chinese found a U-shaped association in which either extreme short 
or long telomere was associated with increased gastric cancer risk90. A potential explanation was 
that while shortened telomere could induce chromosomal instability initiating carcinogenesis, long 
telomeres on the other hand upregulate cell divisions and increase likelihood of abnormalities 
during the process and thus promote cancer development48. However, no association was found in 
prospective studies. A study on two prospective cohorts of over 40,000 participants found that 
telomere length was not associated with gastric cancer risk and death after gastric cancer 
diagnosis91. Therefore, findings from retrospective studies warrant further examination in a 
prospective study setting that could reduce potential selection bias and reverse causality.  
Both in vivo and in vitro studies had shown that telomere length could be associated with 
micronutrients level involved in one carbon metabolism pathway such as vitamin B6, folate, and 
B12. Folate deficiency and high plasma homocysteine level were found to be related with lower 
telomere length among elderly males92. In a previous study in our study population, we observed 
a similar association between high plasma homocysteine and low leukocyte telomere length93. In 
a human cell study where folate deficiency condition was established, rapid elongation of telomere 
in short term followed by sudden shortening of telomere over long period was observed94. 
Meanwhile randomized interventional and observational studies from different populations also 
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demonstrated that dietary folate, vitamin B6, B12, or other one-carbon metabolites are positively 
associated with longer telomere length95-97. However, the interrelationship between dietary folate, 
telomere length and risk of gastric cancer remains unclear. We hypothesis that dietary folate, B6 
or B12 intake could mediate the association between telomere length and risk of developing gastric 
cancer.  
Therefore, we conducted a prospective analysis on participants in SCHS with blood sample 
collected to: 1) examine the role of telomere length in gastric cancer development; 2) whether this 
association differ by dietary folate, vitamin B6 or B12 intake level. 
4.2 METHODS AND MATERIAL 
4.2.1 Study design and population 
Among 63,257 participants of the Singapore Chinese Health Study, a population-based 
prospective cohort of Chinese men and women aged 45-74 years recruited between 1993 and 1998, 
28,219 provided baseline blood samples. The details of SCHS has been previously described53. 
Basically, the study participants were citizens or permanent residents living in the government 
housing estates and belonged to one of two major Chinese dialect groups (Cantonese and 
Hokkien). The present analysis included 26,540 (12,234 males and 14,306 females) subjects with 
available TSR values after excluding samples with insufficient DNA (n = 194) and/or patients with 
prevalent cancer at baseline blood draw (n = 1,465).  
During baseline in-person interviews, a structure questionnaire was used for each 
participant to assess demographics, body weight and height, tobacco smoking, alcohol 
consumption, physical activity, diet, medical history and family history of cancer. Information on 
dietary consumption was obtained using a structured semi-quantitative food frequency 
questionnaire (FFQ) with 165 listed dietary items representing majority of food and beverage items 
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commonly consumed by the study population in Singapore. Dietary nutrients intake was derived 
based on the Singapore Food Composition Table designated for this study and has been validated 
with 24-hour dietary recall interview53. In the first follow-up telephone interviews (FU1) that took 
place in 1999-2004, information on body mass index (BMI), smoking status, number of cigarettes 
smoked per day and years of smoking were updated on 97% of included subjects.  
4.2.2 Case ascertainment 
Incident gastric cancer cases were identified from the Singapore Cancer Registry under the 
National Registry of Diseases Offices (NRDO) of Singapore by linkage analysis. Since 1968, the 
national cancer registry has provided information on cancer trend and patterns98 and have been 
shown to be complete in recording of incident cancer cases99. Gastric adenocarcinoma was defined 
using the International Classification of Disease Oncology, 3rd edition (ICD-O-3) as primary site 
of C16.0-C16.9 and histology type of 8140/3-8560/3.  
4.2.3 Telomere length measurement 
Genomic DNA were extracted from leukocytes in peripheral blood samples by standard 
procedures and was stored at 4°C until analysis. Evidence had shown that human average 
leukocyte telomere length is highly correlated with telomere length in other tissues100. Quantitative 
polymerase chain reaction (PCR) method developed by Cawthon101 was applied to quantify 
relative telomere length determined by the ratio of telomere repeat copy number (T) to single-copy 
gene for albumin (S) (i.e., TSR) on all subjects. In a random selected sample, TSR measurements 
showed high correlation with absolute telomere measurements using Western blot method 
(r=0.91). Each 10 μl experimental sample contained 20ng of DNA diluted in pure water and was 
aliquoted into the reaction well of a 96-well plate compatible with the Bio-Rad MyiQ Single Color 
Real-Time PCR Detection system. Standard DNA curve was drawn based on five concentrations 
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(1.85-150 ng/μl by 3-fold incremental increase) of reference DNA sample. All experimental DNA 
samples were assayed in duplicates. The mean percentage of coefficients of variability was 3.5%. 
4.2.4 H. pylori infection status testing 
To further examine the association of telomere length adjusting for H. pylori infection 
status in relation to gastric adenocarcinoma risk, a nested case-control study was conducted 
involving 522 subjects (133 gastric adenocarcinoma cases and 389 individually matched controls) 
whose serological H. pylori infection status was determined by the presence or absence of CagA 
116 kDa in serum. The details of this case-control study have been previously reported55. A total 
of 511 (128 cases, 383 controls) of them who provided blood sample for telomere length 
measurement was included in the final analysis.  
4.2.5 Statistical analysis 
Baseline demographic and lifestyle information was compared by quintiles of TSR. Cox 
proportional hazard regression method was used to estimate hazard ratios (HRs) and the 
corresponding 95% confidence intervals (CIs) of developing gastric adenocarcinoma for different 
levels of quintile TSR for all subjects and by gender. Person-years of follow-up were computed 
from the blood sample collection date to the date of gastric cancer diagnosis, death, migration out 
of Singapore, or December 31, 2015, whichever occurred first. Age was calculated from the date 
of birth to blood sample collection date. To obtain the most recent information before blood 
collection, BMI, smoking status, pack-years of smoking, alcohol consumption status, and ethanol 
intake information were updated based on FU1 survey. If FU1 data was missing, then baseline 
information was used. The proportional hazards assumption was examined by testing the 
significance of Pearson’s correlation coefficient between Schoenfeld residuals of the composite 
lifestyle score and ranked survival time87. We found no violation of proportional hazards 
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assumption. To characterize the dose-response associations between TSR level and risk of gastric 
adenocarcinoma, restricted cubic spline (RCS) analysis was applied and non-linearity test was 
conducted for the overall dose-response relation102. Predefined knots were located at 5th, 30th, 70th 
and 95th percentile of log transformed TSR distribution. 
To adjust for potential confounding, age, sex, dialect group, year of recruitment, and level 
of education were included in all regression models. Further adjustment for other covariates such 
as intake of individual vegetables and fruit, family history of cancer and history of gastric/duodenal 
ulcer did not meaningfully alter the association between the composite lifestyle score and gastric 
adenocarcinoma risk. Thus the results presented were not adjusted for these variables.  
Stratified analysis was conducted by gender and median age of gastric adenocarcinoma 
cases at 67 years old. To examine the potential modifying effect of subclinical symptoms of gastric 
cancer on the association between composite protective lifestyle score and gastric adenocarcinoma 
risk, we conducted sensitivity analyses on subset of dataset divided by the length of follow-up, e.g.  
≤5 years and >5 years. To investigate the association between telomere length and gastric 
adenocarcinoma risk with adjustment of H. pylori infection status, conditional logistic regression 
model was performed in the nested case-control study for all subjects and for subjects with positive 
H. pylori infection status defined by positive CagA test results. 
Dietary folacin, B6 and B12 intake were adjusted by total energy intake of per 1,000 kcal 
and quartile categorized. Based on ANOVA of average telomere length between each quartile, 
each nutrient was reclassified as dichotomized groups at different cutoffs (B6: 1st quartile; folate: 
4th quartile; B12: median). Stratified analysis of telomere length and risk of gastric 
adenocarcinoma was conducted by each nutrient. Test for the interaction was conducted by 
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examining the statistical significance of interaction term between dichotomized nutrient intake and 
quintile telomere length in the Cox model. 
All statistical analysis was performed in SAS 9.4 software package (SAS Institute, Inc.). 
All P values reported are two-sided. P values <0.05 were considered as statistically significant. 
4.3 RESULTS 
The comparison of baseline characteristics of 26,540 subjects by quintiles of TSR 
measurement was shown in Table 3.1. Overall, the mean of TSR was 1.02 with standard deviation 
of 0.23 (data not shown). Longer TSR measurement was characterized by higher age, females, 
higher education level (≥Secondary level), fewer current smokers and weekly drinkers, and higher 
sodium, vegetable and fruit intakes.   
After 314,226 person-years of follow-up (mean 11.8 years per subject), as of December 
31, 2015, a total of 265 incident cases of gastric cancer were identified. Among them, 17 cases 
were sarcoma, 12 lymphomas and 16 malignancies with unspecified histology; all of them were 
excluded from the present analysis. Thus the present study included 220 cases of gastric 
adenocarcinoma. The mean follow-up time from baseline to gastric adenocarcinoma diagnosis was 
6.13 years (standard deviation=4.01).  
Based on RCS analysis, a U-shaped association was found between TSR levels and risk of 
gastric adenocarcinoma (Figure 2) with a significant non-linear relation (P-value for non-linearity 
test=0.020). Extreme short length of telomere was statistical significantly associated with an 
increased risk of gastric adenocarcinoma, while there was an marginal significant association for 
extreme long telomere length (Table 3.2). Compared with the 2nd quintile, HRs (95% CI) for the 
lowest and highest quintile of TSR were 1.63 (1.08-2.47) and 1.55 (0.97-2.47), respectively after 
adjusting for age, sex, education, interview year, dialect group and smoking status. The U-shaped 
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association was stronger among males but no association was found among females (Table 3.3). 
The association was both present for short (≤5 years) and long (>5 years) duration of follow-up of 
the entire cohort (Table 3.4). 
To examine whether H. pylori infection would impact the association between TSR levels 
and risk of gastric adenocarcinoma, a nested case-control study was conducted within the SCHS 
whose serological status of H. pylori infection was determined by the presence or absence of CagA 
in serum. After adjusting for CagA positivity status, the U-shaped association remained unchanged 
(Table 3.5). The association attenuated slightly after restricting to subjects with positive CagA 
status (Table 3.5). 
4.4 DISCUSSION 
In this prospective cohort study of 26,540 men and women aged 45 to 74, we found that 
extreme short and long telomere length was associated with an 63% and 55% increased risk of 
gastric adenocarcinoma. The association was even stronger among male participants. H. pylori 
infection status did not alter the observed association significantly.  
 Mounting evidence pointed out that short telomere length was associated with higher 
cancer risk including bladder, esophageal, gastric, head and neck, ovarian and renal89. The 
evidence on gastric cancer was solely based on retrospective studies. In a population-based case-
control study conducted among residents aged between 21 to 79 years old in Poland, a total of 300 
invasive gastric adenocarcinoma cases diagnosed between 1994 and 1996 and 416 matched 
controls were enrolled. Shortest quartile of telomere length almost doubled the risk of gastric 
cancer compared with the highest quartile (Odds Ratio=2.04, 95% CI: 1.33-3.13)103. In the same 
study, environmental factors such as positive H. pylori infection status, ever smoking and low fruit 
intake were found to have short telomere length103. Another hospital-based case-control study 
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conducted in China recruited 396 incident gastric adenocarcinoma cases diagnosed between 2007 
and 2008 and 378 healthy controls. The below median telomere length was associated with 
increased risk of gastric adenocarcinoma (OR=2.14, 95% CI: 1.52-2.93)44. More recently, a 
community-based case-control study in China on 1,136 incident gastric cancer cases and 1,012 
cancer-free controls showed a U-shaped association between telomere length and gastric cancer 
risk. Both the highest fifth quintile (OR=1.78, 95% CI: 1.30-2.44) and shortest first quintile 
(OR=3.81, 95% CI: 2.82-5.13) were associated with higher risk of gastric cancer compared with 
the fourth quintile90. Our findings were consistent with previous studies and further corroborate 
the association between extreme telomere length and high risk of gastric cancer in a prospective 
study setting.  
 There is inconsistent evidence regarding telomere length and gastric cancer survivability. 
A study based on two prospective cohorts of over 47,000 subjects among Danish general 
population found that shortening telomere length was not associated with risk of death (HR for 1 
kilobase decrease in telomere length: 0.97, 95%CI: 0.57, 1.67). On the other hand, another study 
on 693 gastric cancer patients in China found an increased risk of mortality for short telomere 
length (HR=2.78, 95% CI: 1.24, 4.48) compared with long length. In our study, no association was 
found between telomere length and risk of mortality. However, there is a nonsignificant pattern of 
low survivability for both extreme long and short telomere length based on the adjusted survival 
curve. Our sample size of 155 deaths among 218 cases have only 75.9% power to detect a hazard 
ratio of 2.78. Future studies are needed to further clarify this association.  
 Emerged evidence could help explain the biological plausibility for the U-shaped 
association found in our study population. On one hand, shortened telomere length could lead to 
chromosome instability, cell inflammation and neoplastic changes in gastric mucosa cells during 
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early carcinogenesis. Previous study on 86 stage I-IV gastric cancer patients found that telomere 
length was significantly shorter in stage I tumor cells compared with its adjacent non-cancer 
mucosa104. In a matched case-control study using gastric mucosa biopsies from 217 gastric cancer 
patients and 102 controls, shortened telomere length was both associated with chronic 
inflammation (P=0.002) and intestinal metaplasia (P<0.001)105. Besides, short telomere length 
could induce epigenetic transformations. In vitro study of five gastric mucosa cell lines from 
cancer-free subjects, telomere shortening was associated with an 71% increased risk of hyper 
methylation in regional promoter CpG island106.  
On the other hand, later stage tumor cells were shown to have longer telomere length than 
their early stage counterparts104. One of the possible explanations was upregulation of telomerase, 
a reverse transcriptase enzyme helping maintain telomere length. Long telomere length thus 
increased chance of abnormality with occurrence of more cell divisions48. An increased activity of 
telomerase was reported in more than 85% of cancer cells107. In studies applying therapy to inhibit 
telomerase activity such as antisense human telomerase reverse transcriptase (ahTERT), decreased 
tumor cell proliferative and invasive capability and partial reverse of malignant phenotypes were 
found108, 109. Another explanation is that long telomere length in long term could intrigue 
overwhelming telomere maintenance mechanism and caused accelerated telomere length 
shortening, and thus breaking the homeostatic balance. In a human cell study, the researchers found 
a folate-deficient environment could not only induce long telomere length in short term and rapid 
telomere attrition, but also led to loss of terminal telomeric fragments94. In our study, we found 
that mean age and sex adjusted telomere length is 1.1% higher among highest quartile of dietary 
vitamin B12 intake compared with the lowest (p=0.025). Compared with lowest quintile of serum 
vitamin B12, subjects in the highest quintile also showed a 1.2% increased mean telomere length 
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(p=0.040) after controlling for age and sex. These results were consistent with a previous double-
blind randomized clinical trial among subjects supplemented with vitamin B12, B6 and folic 
acid97. Vitamin B12 deficiency was associated with elevated methylmalonic acid and shortened 
telomere length97. Vitamin B12 is a critical player in one carbon metabolism as it is a coenzyme 
for methionine synthase to generate methionine from homocysteine96, 97. Vitamin B12 deficiency 
could results in homocysteine accumulation and lack of methionine, a methyl donor for the 
maintenance of DNA methylation and telomere length92. 
Genetic variants may also help elucidate the role of long telomere length in gastric cancer 
development. Evidence showed there was a low expression of genes controlling and decreasing 
telomere length. Compared with non-cancerous gastric mucosa tissue, a down-regulation of 
telomeric repeat binding factor 1 and 2 (TRF1, TRF2) and TRF1-interacting nuclear protein 2 
(TIN2) mRNAs was detected in mucosa tissue from gastric cancer subjects110. Study also 
identified copy number changes in certain chromosome regions related with elevated telomerase 
activity level and longer telomere length among gastric cancer subjects111. 
We found a stronger association between telomere length and risk of gastric 
adenocarcinoma among male subjects but not among female subjects. One of the possible 
explanations is that worldwide males have higher background gastric cancer risk than females18, 
19. The event rate in this study was higher among males (1,144.4 per 100,000) than among females 
(559.2 per 100,000). Relative risk difference due to variation of telomere length is more evident 
among higher absolute risk group. Also in our study females (TSR=1.05) have higher average 
telomere length than males (TSR=1.00). There are fewer female subjects in the shortest quintile 
of telomere length with higher risk of gastric adenocarcinoma.  
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The study association was only present among younger age group. Evidence regarding 
telomere length and gastric cancer risk by age groups is not consistent. While some study found 
the association between shortened telomere length and increase risk of gastric cancer in both 
younger and elder age group44, other study found the association only among elder age group103. 
A case-control study on 598 cases and 2,212 controls found that the longest telomere length 
increased risk of colorectal cancer compared with the median among young age group (≤50 years), 
while shortest telomere length increased the risk among elder age group (>50 years)112. Our study 
finding of both extreme short and long telomere length in relation to increased risk of gastric 
adenocarcinoma only among the younger age group is inconsistent with previous ones. The 
underlying reason for a more pronounced association between telomere length and cancer risk in 
younger population is not clear. Telomere length on average shortens with the aging process. 
Extreme short telomere length among the younger group may indicate underlying variants on 
genes related with shortened telomere length. A meta-analysis of genome wide association studies 
(GWAS) on 21 cohorts of 48,000 individuals have identified multiple SNPs on candidate genes 
such as telomerase reverse transcriptase (TERT) and telomerase RNA component (TERC) in 
relation to telomere length shortening113. On the other hand, extreme long telomere length among 
younger age group could possibly indicate a systematic disruption of telomere length maintenance 
and thus escape from programmed cell death. No association found among older age group could 
possibly be due to increased background risk of gastric cancer due to aging, and thus average out 
the telomere effect. 
 The strength of current study was its prospective study design, relative large sample size 
of more than 24,000 subjects with long-term follow-up of around 12 years, and serological status 
of H. pylori infection. We applied the monochrome multiplex quantitative PCR (MMQPCR) to 
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measure TSR. Compared with the conventional qPCR method, MMqPCR method reduced 
potential inter-sample error and normalizes differences in DNA concentration. There are several 
limitations in our study. All the information on lifestyle was self-reported at baseline with inherent 
non-differential misclassification. Also around 3% of subjects did not have follow-up survey 
information. Thus we could not obtain the updated information on smoking, alcohol drinking and 
BMI at time of blood collection. Our study population was middle-aged during baseline enrollment 
and thus we could do increased our study scope to younger population with average longer 
telomere length. 
 In conclusion, in this prospective cohort study we showed that either extreme short or long 
telomere length was associated with an increased risk of gastric adenocarcinoma among Chinese 
men and women in Singapore. Our study findings support the biological mechanism that both 
shortening and elongation of telomere length are involved in gastric carcinogenesis. Further 
prospective studies are needed to verify our findings in other populations. 
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APPENDIX A: MANUSCRIPT TABLES 
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A.1 TABLES FOR CHAPTER ONE 
Table 1.1. Distribution of selected baseline characteristics of female participants of ever HRT and/or OC use, the Singapore Chinese Health Study, 1993-
2013 
 Total cohort 
(n=34,022) 
 HRT1 and/or OC use 
P value2   Ever 
(n=11,640) 
Never 
(n=22,382) Characteristics  
Age at interview (years), Mean (SD) 56.2 (8.0)  52.9 (6.2) 58.0 (8.3) <0.001 
Body mass index (kg/m2), Mean (SD) 23.2 (3.3)  23.2 (3.3) 23.3 (3.3) 0.550 
Total energy intake (Kcal), Mean (SD) 1,399.0 (472.6)  1,437.2 (468.7) 1,379.1 (473.5) <0.001 
Fruit intake (g/day), Mean (SD) 194.0 (162.1)  214.6 (168.2) 183.1 (157.7) <0.001 
Vegetable intake (g/day ), Mean (SD) 109.9 (61.9)  116.4 (63.8) 106.5 (61.1) <0.001 
Sodium intake (mg/day), Mean (SD) 1010.7 (533.1)  1065.8 (536.8) 982.1 (529.0) <0.001 
Daily coffee drinker, N (%) 23,667 (69.6)  7,963 (68.4) 15,704 (70.2) 0.001 
Education, ≥secondary level, N (%) 7,043 (20.7)  3,132 (26.9) 3,911 (17.5) <0.001 
Alcohol use, N (%)     <0.001 
    Nondrinker 30,933 (90.9)  10,379 (89.2) 20,554 (91.8)  
< 7 drinks/week 2,697 (7.9)  1,140 (9.8) 1,557 (7.0)  
≥7 drinks/week 392 (1.2)  121 (1.0) 271 (1.2)  
Smoking status, N (%)     <0.001 
    Never 31,058 (91.3)  10,954 (94.1) 20,104 (89.8)  
    Former 841 (2.5)  202 (1.7) 639 (2.9)  
    Current 2,123 (6.2)  484 (4.2) 1,639 (7.3)  
Age at menarche (years), Mean (SD) 14.4 (1.7)  14.1 (1.8) 14.6 (1.8) <0.001 
Age at menopause (years), Mean (SD) 49.4 (4.3)  48.9 (4.4) 49.6 (4.2) <0.001 
Nulliparous, N (%)   2,387 (7.0)  373 (3.2) 2,014 (9.0) <0.001 
# of live births among parous women, Mean (SD) 3.5 (1.6)  3.2 (1.4) 3.6 (1.6) <0.001 
Age at first birth, ≥31 years, N (%)  3376 (9.9)  956 (8.2) 2,420 (10.8) <0.001 
Menopausal status/type, N(%)      
    Premenopausal  9,593 (28.2)  4,332 (37.2) 5,261 (23.5) <0.001 
    Postmenopausal 24,429 (71.8)  7,308 (62.8) 17,121 (76.5)  
       Natural   21,341 (87.4)  5,546 (75.9) 15,795 (92.3) <0.001 
       Other means 3,088 (12.6)  1,762 (24.1) 1,326 (7.7)  
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Table 1.1 Continued      
Hysterectomy/Oophorectomy status3, N (%)     <0.001 
No hysterectomy or oophorectomy 29,941 (89.1)  9,490 (82.3) 20,451 (91.9)  
Hysterectomy with no ovary removed 1,483 (4.4)  695(6.1) 788 (3.6)  
Hysterectomy+1 ovary removed 229 (0.7)  146 (1.3) 83 (0.4)  
Hysterectomy+2 ovaries removed 1,100 (3.3)  760 (6.6) 340 (1.5)  
Hysterectomy+ovaries removed (number unknown) 142 (0.4)  67 (0.6) 75 (0.3)  
Oophorectomy without hysterectomy  715 (2.1)  314 (2.7) 401 (1.8)  
HRT1 and/or OC Use, N (%)      
    HRT Only ----  2,651 (22.8) ----  
    OC Only ----  7,348 (63.1) ----  
    HRT and OC ----  1,641 (14.1) ----  
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Table 1.2. Hazard ratios (HRs) and 95% confidence intervals (CIs) for reproductive factors and gastric cancer 
risk, The Singapore Chinese Health Study, 1993-2013 
Characteristics1 Person-year Cases (n) HR (95% CI)2 
Age at menarche    
<13 yrs 82,121 24 1.00 (ref.) 
13-14 yrs 221,119 93 1.11 (0.70-1.74) 
15-16 yrs 196,527 107 1.17 (0.74-1.86) 
≥17 yrs 71,539 45 1.15 (0.69-1.93) 
Parity    
Nulliparous 39,481 22 1.00 (ref.) 
Parous 531,825 247 0.67 (0.43-1.04) 
Number of Children    
0 39,481 22 1.00 (ref.) 
1-2 164,171 56 0.69 (0.42-1.14) 
3-4 217,593 76 0.59 (0.36-0.95) 
≥5 150,061 15 0.74 (0.46-1.19) 
Age at first birth among parous women    
≤20 yrs 106,249 76 1.00 (ref.) 
21-25 yrs 219,053 97 0.80 (0.59-1.08) 
26-30 yrs 148,292 55 0.87 (0.60-1.26) 
    ≥31 yrs 57,859 19 0.76 (0.46-1.28) 
Menstrual Status     
    Premenopausal 170,727 34 1.00 (ref.) 
    Postmenopausal 400,579 235 1.29 (0.83-2.00) 
Age at natural menopause   
<45 yrs  25,257 22 1.00 (ref.) 
45-49 yrs  104,811 70 0.88 (0.54-1.42) 
50-54 yrs  188,237 118 0.78 (0.49-1.23) 
≥55 yrs  29,430 13 0.50 (0.25-0.99)3 
Type of menopause     
    Natural  347,734 223 1.00 (ref.) 
    Other means 52,845 12 0.48 (0.27-0.87) 
Oophorectomy and hysterectomy status    
    No Oophorectomy or hysterectomy  501,104 244 1.00 (ref.) 
Hysterectomy with no ovary removed4  30,690 14 0.94 (0.55-1.61) 
Oophorectomy with/without hysterectomy 37,949 11 0.68 (0.37-1.24) 
Years of menstrual cycling5     
Quartile 1 (≤28.4) 122,299 75 1.00 (ref.) 
Quartile 2 (>28.4 and ≤31.9) 139,923 51 0.67 (0.47-0.96) 
Quartile 3 (>31.9 and ≤34.4) 136,550 82 0.91 (0.66-1.24) 
Quartile 4 (>34.4) 119,048 49 0.67 (0.46-0.96) 
1 All the information is provided by the baseline interview only. 
2 Cox proportional hazard regression model included the following covariates: age at baseline interview (in years), 
baseline interview year (1993-1995, 1996-1998), father’s dialect (Cantonese, Hokkien), body mass index (in kg/m2), 
education (no formal/primary, ≥secondary education), smoking status (never/former, current), daily coffee drinking 
status (yes vs. no), and sodium intake (in mg/day). 
3 P for trend = 0.04. 
4 Includes women who had a hysterectomy, but did not know whether their ovaries were removed.   
5 Among premenopausal and natural postmenopausal women.  
 
48 
 
Table 1.3. Hazard ratios (HRs) and 95% confidence intervals (CIs) for exogenous hormone use and gastric 
cancer risk, The Singapore Chinese Health Study, 1993-2013  
Characteristics Person-years Cases (n) HR (95% CI)1 
HRT use2     
    Never 494,951 253 1.00 (ref.) 
    Ever 76,355 16 0.72 (0.43-1.21) 
HRT use duration2     
    Never users  498,227 253 1.00 (ref.) 
    <1yr 4,617 4 1.84 (0.68-4.95) 
    1-3 yrs  15,909 6 1.20 (0.53-2.73) 
    >3 yrs 52,553 6 0.40 (0.17-0.90) 
OC use at baseline    
    Never 415,452 228 1.00 (ref.) 
    Ever 155,854 41 0.67 (0.47-0.94) 
Duration of OC use at baseline, 
 
   
    Never users  415,452 228 1.00 (ref.) 
    ≤ 2   75,879 19 0.66 (0.41-1.07) 
    >2   79,975 22 0.68 (0.43-1.05)3 
Abbreviations: Hormone replacement therapy (HRT), Oral contraceptive (OC) 
1 Cox proportional hazard regression model included the following covariates: age at baseline interview (in years), 
baseline interview year (1993-1995, 1996-1998), father’s dialect (Cantonese, Hokkien), body mass index (in kg/m2), 
education (no formal/primary, ≥secondary education), smoking status (never/former, current), daily coffee drinking 
(yes, no), and sodium intake (in mg/day). 
2 HRT use is based on information provided at baseline and at follow-up interviews (see Methods for details).  
3 P for trend = 0.03. 
 
 
 
 
 
 
 
 
49 
 
Table 1.4. Odds rations(ORs) and 95% confidence intervals (CIs) of gastric cancer in relation to use of exogenous estrogen use, age at natural menopause 
and total years of menstrual cycling over lifetime among subjects with measurement of H. pylori infection (CagA) status, The Singapore Chinese Health 
Study 
 All subjects  H. pylori-positive only 
 Ca/Co1 OR (95% CI)2  Ca/Co1 OR (95% CI)2 
Total 48/139   48/115  
HRT3 and/or OC use      
    No 33/83 1.00 (ref.)  33/69 1.00 (ref.) 
    Yes 15/56 0.76 (0.33-1.76)  15/46 0.72 (0.30-1.71) 
Years of menstrual cycling4      
Quartile 1 (≤28.4) 16/29 1.00 (ref.)  16/25 1.00 (ref.) 
Quartile 2 (>28.4 and ≤31.9) 9/27 0.58 (0.19, 1.39)  9/24 0.54 (0.17, 1.67) 
Quartile 3 (>31.9 and ≤34.4) 9/41 0.32 (0.10, 0.92) 
 
 9/32 0.35 (0.11, 1.11) 
Quartile 4 (>34.4) 11/25 1.00 (0.34, 2.98)  11/18 1.20 (0.38, 3.78) 
Abbreviations: Hormone replacement therapy (HRT), Oral contraceptive (OC) 
1 Number of cases (Ca) and controls (Co). 
2 ORs were derived from unconditional logistic regression models that included the following covariates: age at baseline interview (in years), baseline interview year (1993-
1995, 1996-1998), father’s dialect (Cantonese, Hokkien), body mass index (in kg/m2), education (no formal/primary, ≥secondary), smoking status (never/former, current), 
daily coffee drinking (yes, no), sodium intake (in mg/day), and date of biospecimen collection. 
3 HRT use is based on information provided at baseline and at follow-up interviews (see Methods for details).    
4 Among premenopausal and natural postmenopausal women. 
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Table 1.5. Hazard ratios (HRs) and 95% confidence intervals (CIs) for exogenous hormone use and gastric cancer risk stratified by body mass index 
(BMI), The Singapore Chinese Health Study, 1993-2013 
 BMI  
<median (23.2 kg/m2) 
 BMI  
≥median (23.2 kg/m2) 
P for 
interaction 
Characteristics Cases (n) HR (95% CI)1  Cases (n) HR (95% CI)1  
HRT use       
  Never 110 1.00 (ref.)  143 1.00 (ref.) 0.8 
  Ever 8 0.72 (0.34-1.51)  8 0.72 (0.35-1.50)  
OC use at baseline       
  Never  102 1.00 (ref.)  126 1.00 (ref.) 0.5 
  Ever 16 0.62 (0.36-1.06)  25 0.73 (0.46, 1.14)  
Duration of OC use at 
baseline, years 
      
  Never users 102 1.00 (ref.)  126 1.00 (ref.) 0.8 
  ≤ 2 6 0.48 (0.21-1.11)  13 0.85 (0.47-1.53)  
  >2 10 0.74 (0.38-1.43)  12 0.62 (0.33-1.16)  
Abbreviations: Hormone replacement therapy (HRT), Oral contraceptive (OC) 
1 Cox proportional hazard regression model included the following covariates: age at baseline interview (in years), baseline interview year (1993-1995, 1996-1998), 
father’s dialect (Cantonese, Hokkien), body mass index (in kg/m2), education (no formal/primary, ≥secondary education), smoking status (never/former, current), daily 
coffee drinking (yes, no), and sodium intake (in mg/day). 
2 HRT use is based on information provided at baseline and at follow-up interviews (see Methods for details) 
.
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A.2 TABLES FOR CHAPTER TWO 
Table 2.1. Distribution of selected baseline characteristics of all participants by composite lifestyle scores (5 factors), The Singapore Chinese Health Study, 
1993-2014 
Characteristics Composite lifestyle scores 0/1/2 3 4 5 
N 6,223 20,017 24,799 10,282 
Age in years, mean (SD) 56.4 (7.7) 55.9 (7.9) 56.6 (8.1) 56.9 (7.9) 
BMI (kg/m2), mean (SD) 24.8 (4.5) 23.3 (3.5) 22.8 (2.8) 22.5 (2.4) 
Female, % 21.8 50.5 61.5 71.2 
Education level, %     
    No formal education 20.2 24.7 30.0 30.0 
    Primary school  52.8 44.8 43.0 41.5 
    ≥Secondary level 27.0 30.5 27.0 28.5 
Smoking status, %     
    Never smoker 25.4 63.5 78.2 87.0 
    Former smoker 21.3 12.8 8.6 6.3 
    Current smoker 53.3 23.7 13.2 6.7 
Smoking amount among ever smokers, mean (SD)     
    Number of cigarettes/day 24.1 (11.2) 18.1 (11.1) 12.3 (9.0) 9.2 (6.2) 
    Number of years of smoking 36.4 (8.8) 33.6 (11.4) 30.5 (12.7) 28.2 (13.6) 
    Pack-years of smoking 43.8 (21.9) 31.2 (22.4) 18.5 (16.4) 11.8 (7.4) 
Alcohol consumption status, %     
 Non-drinkers 58.9 77.9 86.4 91.4 
   Drinkers 41.1 22.1 13.6 8.6 
Ethanol intake (g/day) among drinkers, mean (SD) 20.6 (22.3) 8.4 (14.2) 3.3 (5.9) 2.0 (1.8) 
Daily sodium intake (mg), mean(SD) 1,607.9 (784.4) 1,361.0 (663.3) 915.1 (414.8) 816.9 (319.4) 
Food consumption in grams, mean (SD)     
 Total vegetables 113.5 (67.9) 110.2 (62.3) 99.2 (58.3) 137.3 (67.0) 
 Total fruits 183.9 (174.5) 194.7 (161.9) 191.1 (160.3) 256.8 (189.9) 
   Total red meat 46.9 (32.0) 37.7 (26.0) 25.6 (19.2) 18.7 (15.2) 
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Table 2.2. Lifestyle factors and gastric adenocarcinoma risk among all participants (n=61,321), The Singapore Chinese Health Study, 1993-2014 
Characteristics Person-years All cases Cardia Non-cardia Cases HR (95% CI)1 Cases HR (95% CI)1 Cases HR (95% CI)1 
Smoking  
    Pack-years of smoking >21.9 132,949 187 1.00 (ref.) 37 1.00 (ref.) 128 1.00 (ref.) 
    Pack-years of smoking ≤21.9 906,112 504 0.66 (0.55-0.83) 81 0.54 (0.35-0.84) 363 0.66 (0.53-0.83) 
Alcohol 
    Daily ethanol intake >8.1g 62,238 70 1.00 (ref.) 11 1.00 (ref.) 51 1.00 (ref.) 
    Daily ethanol intake ≤8.1g  976,823 621 0.69 (0.53-0.89) 107 0.86 (0.45-1.63) 440 0.66 (0.49-0.89) 
Body mass index (BMI) 
    ≥27.5 kg/m2  89,879 66 1.00 (ref.) 16 1.00 (ref.) 47 1.00 (ref.) 
    <27.5 kg/m2  949,182 635 0.80 (0.62-1.03) 102 0.54 (0.32-0.93) 444 0.79 (0.58-1.07) 
Dietary pattern score 
    <62 774,142 549 1.00 (ref.) 101 1.00 (ref.) 383 1.00 (ref.) 
    ≥62 264,919 142 0.82 (0.68-0.99) 17 0.60 (0.35-1.01) 108 0.89 (0.71-1.11) 
Sodium intake 
    ≥ 782 mg per 1,000 kcal energy 340,708 242 1.00 (ref.) 48 1.00 (ref.) 161 1.00 (ref.) 
    < 782 mg per 1,000 kcal energy 698,353 449 0.80 (0.68-0.94) 70 0.64 (0.44-0.93) 330 0.87 (0.72-1.05) 
Composite scores (5 factors)2 
    0/1/2 97,712 123 1.00 (ref.) 30 1.00 (ref.) 77 1.00 (ref.) 
    3 334,135 246 0.68 (0.52-0.88) 41 0.49 (0.30-0.79) 179 0.80 (0.61-1.04) 
    4 427,141 237 0.51 (0.40-0.66) 38 0.36 (0.22-0.60) 169 0.57 (0.43-0.76) 
    5 180,074 85 0.42 (0.31-0.57) 9 0.22 (0.10-0.47) 66 0.55 (0.39-0.78) 
    P trend   <0.001  <0.001  <0.001 
    PAR (95% CI)   0.48 (0.36-0.59)  0.72 (0.51-0.84)  0.43 (0.27-0.57) 
 Composite Z-score (5 factors) 
    1st Quartile  251,028 212 1.00 (ref.) 44 1.00 (ref.) 140 1.00 (ref.) 
    2nd Quartile 258,747 167 0.76 (0.62-0.93) 29 0.64 (0.40-1.02) 129 0.88 (0.70-1.12) 
    3rd Quartile 263,404 162 0.72 (0.58-0.88) 25 0.54 (0.33-0.88) 109 0.72 (0.56-0.92) 
    4th Quartile 265,881 150 0.64 (0.51-0.78) 20 0.42 (0.25-0.71) 113 0.71 (0.55-0.91) 
    P trend   <0.001  0.001  0.002 
Abbreviations: HR=hazard ratio; CI=confidence interval; PAR=population attributable risk 
1 For single lifestyle factor, model included all factors simultaneously and adjusted age at baseline interview (in years), baseline interview year (1993-1995, 1996-
1998), father’s dialect (Cantonese, Hokkien), gender, and education (no formal education, primary education, ≥secondary education) 
2 Model adjusted for age at baseline interview (in years), baseline interview year (1993-1995, 1996-1998), father’s dialect (Cantonese, Hokkien), gender, and 
education (no formal/primary, ≥secondary education). 
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Table 2.3. Composite lifestyle score and gastric cancer risk by gender and follow-up time, The Singapore 
Chinese Health Study, 1993-2014 
Characteristics N Cases Person-years HR (95% CI)1 
Male (N=27,293) 
Composite scores (5 factors)     
    0/1/2 4,866 103 74,708 1.00 (ref.) 
    3 9,929 159 158,964 0.72 (0.56-0.92) 
    4 9,543 117 157,918 0.53 (0.40-0.69) 
    5 2,955 33 49,597 0.46 (0.31-0.69) 
    P trend    <0.001 
    PAR (95% CI)    0.50 (0.34-0.63) 
Composite Z-scores (5 factors)     
    1st Quartile  6,823 127 105,697 1.00 (ref.) 
    2nd Quartile 6,824 101 109,148 0.76 (0.58-0.99) 
    3rd Quartile 6,823 97 112,193 0.74 (0.56-0.96) 
    4th Quartile 6,823 87 114,148 0.62 (0.47-0.82) 
    P trend    0.001 
Female (N=34,028) 
Composite scores (5 factors)     
    0/1/2  1,357 19 23,004 1.00 (ref.) 
    3 10,088 88 175,171 0.67 (0.41-1.09) 
    4 15,256 120 269,223 0.52 (0.32-0.84) 
    5 7,327 52 130,477 0.47 (0.28-0.79) 
    P trend    0.003 
    PAR (95% CI)    0.41 (0.18-0.60) 
Composite Z-scores (5 factors)     
    1st Quartile  8,507 85 145,331 1.00 (ref.) 
    2nd Quartile 8,507 66 149,599 0.76 (0.55-1.05) 
    3rd Quartile 8,507 65 151,211 0.70 (0.50-0.96) 
    4th Quartile 8,507 63 151,733 0.66 (0.48-0.92) 
    P trend    0.011 
Abbreviations: HR=hazard ratio; CI=confidence interval; PAR=population attributable risk 
1 Model adjusted for age at baseline interview (in years), baseline interview year (1993-1995, 1996-1998), 
father’s dialect (Cantonese, Hokkien), and education (no formal education, primary education, ≥secondary 
education) 
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Table 2.4 Sensitivity analysis for composite lifestyle score and gastric adenocarcinoma risk by length of follow-
up, The Singapore Chinese Health Study, 1993-2014  
Follow-up time Cases Person-years HR (95% CI)1 
Follow-up ≤5 years 
Composite score (5 factors)    
    0/1/2 36 30,149 1.00 (ref.) 
    3 68 97,487 0.71 (0.47-1.07) 
    4 51 121,335 0.44 (0.28-0.68) 
    5 15 50,499 0.33 (0.18-0.61) 
    P trend   <0.001 
Composite Z-score (5 factors)    
    1st Quartile  66 74,552 1.00 (ref.) 
    2nd Quartile 40 74,837 0.60 (0.41-0.89) 
    3rd Quartile 29 75,022 0.43 (0.28-0.66) 
    4th Quartile 35 75,058 0.50 (0.33-0.76) 
    P trend   <0.001 
Follow-up >5 years 
Composite score (5 factors)    
    0/1/2 86 67,563 1.00 (ref.) 
    3 178 236,648 0.71 (0.55-0.92) 
    4 187 305,805 0.57 (0.43-0.74) 
    5 70 129,575 0.52 (0.38-0.73) 
    P trend   <0.001 
Composite Z-score (5 factors)    
    1st Quartile  146 176,476 1.00 (ref.) 
    2nd Quartile 127 183,910 0.83 (0.66-1.06) 
    3rd Quartile 133 188,382 0.84 (0.66-1.07) 
    4th Quartile 115 190,823 0.70 (0.54-0.89) 
    P trend   0.007 
Abbreviations: HR=hazard ratio; CI=confidence interval; PAR=population attributable risk 
1 Model adjusted for age at baseline interview (in years), baseline interview year (1993-1995, 1996-1998), 
father’s dialect (Cantonese, Hokkien), gender, and education (no formal education, primary education, 
≥secondary education) 
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Table 2.5. Composite lifestyle score and gastric adenocarcinoma risk among subjects with measurement of H. 
pylori infection (CagA) status, The Singapore Chinese Health Study, 1993-2014 
Characteristics All subjects H. pylori-positive only
3 
Ca/Co OR (95% CI)1 OR (95% CI)2 Ca/Co OR (95% CI)1 
All subjects 133/389   128/329  
Composite Score      
  0/1/2 26/46 1.00 (ref.) 1.00 (ref.) 24/39 1.00 (ref.) 
  3 47/112 0.77 (0.43-1.40) 0.78 (0.43-1.42) 46/92 0.78 (0.42-1.46) 
  4 44/161 0.44 (0.24-0.81) 0.43 (0.23-0.81) 43/139 0.42 (0.21-0.82) 
  5 16/70 0.37 (0.16-0.82) 0.36 (0.16-0.82) 15/59 0.34 (0.15-0.80) 
  P trend  0.017 0.017  0.019 
  PAR (95% CI)  0.62 (0.26, 0.82) 0.62 (0.27, 0.83)  0.64 (0.28, 0.84) 
Composite Z-score      
  1st Quartile 48/110 1.00 (ref.) 1.00 (ref.) 46/94 1.00 (ref.) 
  2nd Quartile 28/89 0.71 (0.41-1.22) 0.68 (0.40-1.19) 28/76 0.70 (0.39-1.23) 
  3rd Quartile 34/90 0.79 (0.46-1.38) 0.80 (0.46-1.41) 32/77 0.75 (0.42-1.35) 
  4th Quartile 23/100 0.53 (0.28-0.98) 0.56 (0.29-1.06) 22/82 0.54 (0.27-1.05) 
  P trend  0.068 0.117  0.094 
Cardia cases  24/69   21/60  
Composite Score      
  0/1/2 6/8 1.00 (ref.) 1.00 (ref.) 5/8 1.00 (ref.) 
  3 7/22 0.46 (0.09-2.42) 0.45 (0.08-2.41) 7/17 0.58 (0.10-3.29) 
  4 9/27 0.28 (0.06-1.30) 0.28 (0.06-1.33) 8/25 0.33 (0.06-1.68) 
  5 2/12 0.20 (0.02-1.63) 0.20 (0.02-1.61) 1/10 0.11 (0.01-1.57) 
  P trend  0.074 0.075  0.065 
Composite Z-score      
  1st Quartile 11/23 1.00 (ref.) 1.00 (ref.) 10/20 1.00 (ref.) 
  2nd Quartile 4/15 0.47 (0.12-1.84) 0.47 (0.12-1.87) 4/13 0.53 (0.13-2.17) 
  3rd Quartile 5/17 0.29 (0.06-1.43) 0.29 (0.06-1.44) 4/14 0.33 (0.07-1.65) 
  4th Quartile 4/14 0.62 (0.15-2.59) 0.62 (0.15-2.59) 3/13 0.42 (0.08-2.24) 
  P trend  0.296 0.297  0.195 
Non-cardia cases 88/253   87/212  
Composite Score      
  0/1/2 17/27 1.00 (ref.) 1.00 (ref.) 16/23 1.00 (ref.) 
  3 34/74 0.69 (0.33-1.44) 0.73 (0.34-1.57) 34/60 0.76 (0.35-1.67) 
  4 27/106 0.31 (0.14-0.70) 0.34 (0.14-0.79) 27/90 0.35 (0.15-0.83) 
  5 10/46 0.24 (0.08-0.70) 0.28 (0.10-0.81) 10/39 0.29 (0.10-0.85) 
  P trend  0.009 0.023  0.026 
Composite Z-score      
  1st Quartile 31/68 1.00 (ref.) 1.00 (ref.) 30/59 1.00 (ref.) 
  2nd Quartile 20/58 0.72 (0.37-1.39) 0.72 (0.36-1.43) 20/49 0.72 (0.36-1.44) 
  3rd Quartile 24/59 0.76 (0.38-1.51) 0.86 (0.42-1.75) 24/50 0.87 (0.42-1.80) 
  4th Quartile 13/68 0.36 (0.15-0.83) 0.44 (0.19-1.05) 13/54 0.45 (0.19-1.08) 
  P trend  0.030 0.121  0.139 
Abbreviations: Ca=Cases; Co=Controls; OR=odds ratio; CI=confidence interval, PAR=population attributable risk 
1 Conditional logistic regression model adjusted for age at baseline interview (in years), baseline interview year (1993-
1995, 1996-1998), father’s dialect (Cantonese, Hokkien), gender, and education (no formal education, primary 
education, ≥secondary education) 
2 Further adjusted for serum H. pylori CagA status (positive, negative). 
3 H. pylori positive defined by positive serum CagA status 
 
 
 
 
 
 
56 
 
Table 2.6. Selected food groups intake by high vs. low risk dietary pattern score, The Singapore Chinese Health Study, 1993-2014 (N=61,321) 
Selected food groups High risk (dietary pattern score<62) 
Low risk 
(dietary pattern score≥62) P value
* 
Total vegetables in g/day, mean (SD) 103.2 (58.7) 154.6 (72.3) <0.001 
Total fruits in g/day, mean (SD) 191.1 (161.2) 269.5 (198.3) <0.001 
Total red meat in g/day, mean (SD) 32.7 (24.9) 18.0 (15.1) <0.001 
Tofu products and soy drink in g/day, mean (SD) 106.9 (89.7) 141.0 (111.8) <0.001 
Rice in g/day, mean (SD) 423.3 (205.7) 376.9 (180.0) <0.001 
Noodles in g/day, mean (SD) 57.5 (47.7) 37.3 (36.9) <0.001 
Desert in g/day, mean (SD) 1.9 (4.3) 0.8 (2.3) <0.001 
* P values were derived from the Wilcoxon two-sample test. 
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Table 2.7. Scoring categorization of single lifestyle factor, The Singapore Chinese Health Study, 1993-2014 (N=61,321) 
Lifestyle factor Score (high-risk=0, low-risk=1) High risk (%) Low risk (%) 
Cigarette smoking (pack-years of smoking) >21.9 (14.7%) ≤21.9 (85.3%) 
Daily ethanol intake (g) >8.1 (6.3%) ≤8.1 (93.7%) 
BMI (kg/m2) ≥27.5 (8.7%) <27.5 (91.3%) 
Sodium intake (g/per 1,000 kcal energy) <782 (33.3%) ≥ 782(66.7%) 
Dietary pattern score <62 (25.2%) ≥62 (74.8%) 
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Table 2.8. Distribution of single lifestyle factor by composite lifestyle Z-score, The Singapore Chinese Health Study, 1993-2014 (N=61,321) 
Characteristics Composite lifestyle Z-scores 1st Qrt. 2nd Qrt. 3rd Qrt. 4th Qrt. 
N 15,330 15,331 15,330 15,330 
Pack-years of smoking, mean (SD) 20.2 (26.7) 9.4 (16.5) 4.8 (11.3) 1.6 (6.1) 
Daily ethanol intake in grams, mean (SD) 4.8 (14.3) 1.4 (4.9) 0.7 (3.1) 0.3 (1.6) 
Body mass index (BMI) in kg/m2, mean (SD) 24.9 (3.9) 23.4 (2.8) 22.7 (2.6) 21.5 (2.6) 
Dietary pattern score, mean (SD) 35.9 (15.1) 45.3 (14.3) 52.9 (14.4) 65.5 (14.9) 
Daily sodium intake, mean (SD) 855.7 (216.4) 743.7 (173.4) 658.2 (160.1) 543.2 (151.4) 
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Table 2.9. Distribution of single lifestyle factor by composite lifestyle score, The Singapore Chinese Health Study, 1993-2014 (N=61,321) 
Characteristics Composite lifestyle scores 0/1/2 3 4 5 
N 6,223 20,017 24,799 10,282 
Cigarette smoking, %     
    Pack-years of smoking >21.9 66.0 19.8 3.6 0 
    Pack-years of smoking ≤21.9 34.0 80.2 96.4 100.0 
Alcohol consumption, %     
    Daily ethanol intake >8.1 g 35.8 6.8 1.0 0 
    Daily ethanol intake ≤8.1 g 64.2 93.2 99.0 100.0 
Body mass index (BMI), %     
    BMI ≥27.5 kg/m2 34.4 10.9 3.9 0 
    BMI <27.5 kg/m2 65.6 89.1 96.1 100.0 
Dietary pattern score, %     
    <62 99.4 96.5 81.9 0.0 
    ≥62 0.6 3.5 18.1 100.0 
Daily sodium intake, %     
    ≥782 mg/per 1,000 kcal energy 76.3 66.0 9.6 0 
    <782 mg/per 1,000 kcal energy 23.7 34.0 91.4 100.0 
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Table 2.10. Individual lifestyle factors and gastric adenocarcinoma risk, The Singapore Chinese Health Study, 
1993-2014 
Characteristics Cases Person-years Base model
1 Mutually adjusted model2 
HR (95% CI)1 HR (95% CI)1 
Pack-years of smoking     
  Never smoker 382 749,840 1.00 (ref.) 1.00 (ref.) 
  Ever smoker     
    1st quartile (>0 and ≤11.9) 57 78,593 1.02 (0.77-1.36) 1.02 (0.77-1.36) 
    2nd quartile (>11.9 and ≤21.9) 65 77,679 1.05 (0.79-1.38) 1.04 (0.79-1.38) 
    3rd quartile (>21.9 and ≤39.4) 122 82,660 1.62 (1.28-2.04) 1.58 (1.25-2.00) 
    4th quartile (>39.4) 65 50,289 1.40 (1.05-1.86) 1.33 (0.99-1.78) 
  P trend   <0.001 0.002 
Daily ethanol consumption     
  Non drinker 539 841,575 1.00 (ref.) 1.00 (ref.) 
  Ever drinker     
    ≤ median (8.1 g)  82 135,248 0.93 (0.74-1.18) 0.91 (0.72-1.16) 
    > median (8.1 g)  70 62,238 1.48 (1.14-1.91) 1.40 (1.08-1.83) 
  P trend   0.027 0.019 
Body mass index (BMI)     
  ≤20 kg/m2 87 155,249 1.00 (ref.) 1.00 (ref.) 
  >20 and ≤24 kg/m2 383 561,651 1.16 (0.92-1.46) 1.19 (0.94-1.51) 
  >24 and ≤27.5 kg/m2 162 247,602 1.19 (0.91-1.54) 1.24 (0.96-1.61) 
  >27.5 kg/m2  59 74,459 1.53 (1.10-2.13) 1.58 (1.14-2.21) 
  P trend   0.025 0.057 
Dietary pattern score     
  1st quartile (≥1 and ≤37.5) 183 250,770 1.00 (ref.) 1.00 (ref.) 
  2nd quartile (>37.5 and ≤49.5) 164 255,550 0.89 (0.72-1.10) 0.94 (0.76-1.16) 
  3rd quartile (>49.5 and ≤62.0) 202 267,823 1.02 (0.84-1.26) 1.12 (0.91-1.38) 
  4th quartile (>62.0) 142 264,919 0.76 (0.61-0.95) 0.86 (0.68-1.09) 
  P trend   0.074 0.096 
Sodium intake, mg/1000 kcal energy     
  1st tertile (≤599) 235 341,474 1.00 (ref.) 1.00 (ref.) 
  2nd tertile (>599 and ≤782) 216 356,238 1.00 (0.83-1.21) 1.00 (0.83-1.21) 
  3rd tertile (>782) 240 341,349 1.27 (1.06-1.53)  1.25 (1.04-1.51) 
  P trend   0.010 0.024 
1 Based model adjusted for age at baseline interview (in years), baseline interview year (1993-1995, 1996-1998), 
father’s dialect (Cantonese, Hokkien), gender, and education (no formal education, primary education, 
≥secondary education) 
2 Mutually adjusted model included all the covariates in model A and mutually adjusted for all included 
lifestyle factors 
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Table 2.11. Z-score of individual lifestyle factors and gastric adenocarcinoma risk, The Singapore Chinese 
Health Study, 1993-2014 
Z-score of each lifestyle factor HR (95% CI)1 P value 
    Pack-years of smoking 1.09 (1.02-1.15) 0.005 
    Daily ethanol consumption 1.15 (1.05-1.26) 0.003 
    Body mass index (BMI) 1.09 (1.01-1.17) 0.028 
    Dietary pattern score 0.97 (0.90-1.06) 0.523 
    Daily sodium consumption 1.09 (1.01-1.18) 0.025 
1 For single lifestyle factor, model included all factors simultaneously and adjusted age at baseline interview 
(in years), baseline interview year (1993-1995, 1996-1998), father’s dialect (Cantonese, Hokkien), gender, and 
education (no formal education, primary education, ≥secondary education) 
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A.3 TABLES FOR CHAPTER THREE 
Table 3.1. Distribution of selected baseline characteristics of all participants by TSR, The Singapore Chinese Health Study, 1993-2015 
Characteristics TSR measurements 1st Quintile 2nd Quintile 3rd Quintile 4th Quintile 5th Quintile 
N 5,038 5,038 5,038 5,038 5,038 
Age in years, mean (SD) 65.9 (7.8) 63.8 (7.6) 62.7 (7.5) 61.5 (7.2) 60.1 (6.9) 
BMI (kg/m2), mean (SD) 23.1 (3.5) 23.2 (3.5) 23.3 (3.5) 23.4 (3.5) 23.3 (3.5) 
Female, % 44.8 50.2 53.2 59.1 62.2 
Education level, %      
  No formal education 22.5 21.1 20.5 20.6 19.4 
  Primary school  47.6 44.6 45.4 45.0 44.1 
  ≥Secondary level 29.9 34.3 34.2 34.4 36.5 
Smoking status, %      
  Never smoker 60.5 65.4 68.3 72.0 74.4 
  Former smoker 21.6 17.4 15.3 13.5 12.4 
  Current smoker 17.9 17.2 16.4 14.4 13.2 
Pack-years smoking among ever smokers, mean (SD) 33.6 (29.1) 30.8 (28.6) 30.5 (27.5) 28.1 (24.9) 27.9 (25.9) 
Alcohol consumption status, %      
Non-drinkers 87.9 88.5 88.5 89.1 89.0 
  <7 drinks/week 8.4 8.4 8.5 8.4 8.4 
  ≥7 drinks/week 3.7 3.1 3.0 2.5 2.6 
Ethanol intake (g/day) among drinkers, mean (SD) 10.6 (16.5) 9.2 (15.2) 10.2 (16.9) 7.9 (13.6) 8.6 (15.0) 
Daily sodium intake (mg), mean(SD) 1,122.5 (583) 1,136.9 (599.5) 1,149.7 (595.8) 1,142.3 (596.5) 1,162.8 (618.3) 
Food consumption in grams, mean (SD)      
Total vegetables 112.2 (63.9) 115.9 (64.5) 116.3 (64.7) 116.7 (64) 119.6 (65.9) 
Total fruits 205.6 (165.3) 216.4 (171.7) 210.3 (166.1) 214.9 (167.4) 221.4 (172.9) 
  Total red meat 30.7 (23.5) 31.1 (24.5) 31.7 (25.1) 31.2 (24.3) 31.4 (24.6) 
Physical activity (hours/week), mean (SD) 5.0 (6.2) 4.7 (6.0) 4.9 (6.3) 4.7 (6.0) 4.7 (6.3) 
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Table 3.2. TSR decile and gastric cancer risk, The Singapore Chinese Health Study, 1993-2015 
TSR level Cases Person-years HR (95% CI)1 
  1st Quintile 65 59,791 1.63 (1.08-2.47) 
    2nd Quintile 34 62,053 1.00 (ref.) 
  3rd Quintile 41 63,024 1.30 (0.82-2.04) 
  4th Quintile 41 64,003 1.45 (0.92-2.29) 
  5th Quintile 39 65,355 1.55 (0.97-2.47) 
  Pnon-linear2   0.020 
Abbreviations: HR=hazard ratio; CI=confidence interval 
1 Model adjusted for age at baseline interview (in years), baseline interview year (1993-1995, 1996-1998), father’s dialect (Cantonese, Hokkien), gender, 
education (no formal education, primary education, ≥secondary education), and smoking status (never smoker, former smoker, current smoker) 
2 Based on RCS non-linearity test  
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Table 3.3. TSR decile and gastric cancer risk by gender, The Singapore Chinese Health Study, 1993-2015 
TSR level Male (n=12,234) Female (n=14,306) Cases Person-years HR (95% CI)1 Cases Person-years HR (95% CI)1 
  1st Quintile 47 31,406 1.75 (1.04-2.93) 18 28,385 1.42 (0.69-2.89) 
  2nd Quintile 21 29,425 1.00 (ref.) 13 32,627 1.00 (ref.) 
  3rd Quintile 25 27,903 1.33 (0.74-2.38) 16 35,121 1.24 (0.60-2.57) 
  4th Quintile 23 25,261 1.49 (0.82-2.70) 18 38,742 1.36 (0.66-2.78) 
  5th Quintile 24 23,602 1.88 (1.04-3.40) 15 41,753 1.15 (0.54-2.44) 
  Pnon-linear2   0.009   0.782 
Abbreviations: HR=hazard ratio; CI=confidence interval 
1 Model adjusted for age at baseline interview (in years), baseline interview year (1993-1995, 1996-1998), father’s dialect (Cantonese, Hokkien), gender, 
education (no formal education, primary education, ≥secondary education), and smoking status (never smoker, former smoker, current smoker) 
2 Based on RCS non-linearity test  
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Table 3.4. TSR decile and gastric cancer risk by duration of follow-up, The Singapore Chinese Health Study, 1993-2015 
TSR level Follow-up <5 years  Follow-up ≥5 years Cases Person-years HR (95% CI)1 Cases Person-years HR (95% CI)1 
  1st Quintile 33 25,002 1.73 (0.95-3.15) 32 34,494 1.54 (0.86-2.75) 
  2nd Quintile 16 25,404 1.00 (ref.) 18 36,314 1.00 (ref.) 
  3rd Quintile 19 25,482 1.31 (0.67-2.55) 22 37,211 1.28 (0.69-2.40) 
  4th Quintile 15 25,566 1.18 (0.58-2.40) 26 38,084 1.66 (0.91-3.04) 
  5th Quintile 15 25,611 1.37 (0.67-2.79) 24 39,362 1.69 (0.91-3.15) 
  Pnon-linear2   0.004   0.034 
Abbreviations: HR=hazard ratio; CI=confidence interval 
1 Model adjusted for age at baseline interview (in years), baseline interview year (1993-1995, 1996-1998), father’s dialect (Cantonese, 
Hokkien), gender, education (no formal education, primary education, ≥secondary education), and smoking status (never smoker, former 
smoker, current smoker) 
2 Based on RCS non-linearity test  
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Table 3.5. TSR level and gastric adenocarcinoma risk among subjects with measurement of H. pylori infection (CagA) status, The Singapore Chinese 
Health Study, 1993-2015 
 
 
 
 
 
 
Abbreviations: Ca=Cases; Co=Controls; OR=odds ratio; CI=confidence interval 
1 Conditional logistic regression model adjusted for age at baseline interview (in years), baseline interview year (1993-1995, 1996-1998), father’s dialect 
(Cantonese, Hokkien), gender, and education (no formal education, primary education, ≥secondary education) 
2 Further adjusted for serum H. pylori CagA status (positive, negative). 
3 H. pylori positive defined by positive serum CagA status 
4 Based on RCS non-linearity test  
 
TSR level All subjects H. pylori-positive only
3 
Ca/Co OR (95% CI)1  OR (95% CI)2 Ca/Co OR (95% CI)1 
  1st Quintile 37/98 2.00 (1.04-3.83) 1.94 (0.99-3.78) 37/85 1.92 (0.97-3.82) 
  2nd Quintile 18/87 1.00 (ref.) 1.00 (ref.) 18/74 1.00 (ref.) 
  3rd Quintile 29/78 2.04 (1.05-3.96) 2.04 (1.04-4.00) 29/64 2.02 (1.00-4.06) 
  4th Quintile 24/62 2.12 (1.05-4.30) 2.19 (1.05-4.54) 22/51 1.91 (0.89-4.12) 
  5th Quintile 20/58 2.14 (0.99-4.64) 2.20 (1.00-4.85) 17/50 1.64 (0.72-3.74) 
  Pnon-linear4  0.038 0.031  0.073 
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B.1 FIGURE FOR INTRODUCTION 
 
Figure 1. Correa's model for gastric carcinogenesis 
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B.2 FIGURE FOR CHAPTER ONE 
 
Figure 2. Flow diagram of computing hormone replacement therapy (HRT) use duration1 
 
Abbreviations: FU1=follow-up I interview, FU2=follow-up II interview, d0= HRT use duration reported until 
baseline, d1= years between baseline and FU1 interview dates, d2=years between FU1 and FU2 interview dates, 
T0=self-report HRT use duration until baseline, T1=computed HRT use duration between baseline and FU1 
interview, T2=computed HRT use duration between FU1 and FU2 interview. 
1 Total HRT use duration across the three time points (i.e., at baseline, baseline to FU1, and FU1 to FU2) was based 
on self-reported responses to never, past, or current HRT use at baseline, FU1 and/or FU2.  
 
The followings are three examples to illustrate how total HRT use duration is computed: 
1) If a woman reported never HRT use at baseline, past use at FU1 and current use at FU2, then total duration of 
HRT use would be calculated as follows: 
0.5*(years from baseline to FU1) + 0.5*(years from FU1 to FU2).   
Half of the years from baseline to FU1 and from FU1 to FU2 was included to estimate duration of use during these 
two periods, because the start date of HRT use was not obtained at FU1 or FU2.  
2) If a woman reported past HRT use at baseline, and current use at FU1 and FU2, then total duration of HRT use 
would be calculated as follows: 
(Duration reported at baseline) + 0.5*(years from baseline to FU1) + (years from FU1 to FU2).   
3) If a woman report current HRT use at baseline, past use at FU1 and FU2, then total duration of HRT use would be 
calculated as follows: 
(Duration reported at baseline) + 0.5*(years from baseline to FU1) 
Since participants reported past HRT use at FU1 and FU2, we considered the past HRT use reported at FU2 as a 
repeat of past HRT use reported at FU1. Thus we assumed that the participant did not use HRT between FU1 and 
FU2.  
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B.3 FIGURE FOR CHAPTER THREE 
 
Figure 3. Restricted Cubic Spline1 of TSR and Risk of Gastric Adenocarcinoma 
 
Abbreviations: HR=hazard ratio; CI=confidence interval 
1 Restricted cubic spline at 4 knots located at 5th, 30th, 70th and 95th percentile of ln(TSR) distribution 
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